UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 10-Q

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

 

For the quarterly period ended November 30, 2010

 

 

 

 

 

or

 

 

 

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

 

For the transition period from ..... to …..    

 

 

Commission file number: 001-14669

 

HELEN OF TROY LIMITED

(Exact name of registrant as specified in its charter)

 

Bermuda

 

74-2692550

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

 

 

 

Clarenden House

Church Street

Hamilton, Bermuda

 

 

(Address of principal executive offices)

 

 

 

 

 

1 Helen of Troy Plaza

 

 

El Paso, Texas

 

79912

(Registrant’s United States Mailing Address)

 

(Zip Code)

 

(915) 225-8000

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                                                                    Yes x    No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).        Yes o    No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o

 

Accelerated filer   x

 

 

 

Non-accelerated filer   o (Do not check if a smaller reporting company)

 

Smaller reporting company   o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes o     No x

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class

 

Outstanding at January 4, 2011

Common Shares, $0.10 par value, per share

 

30,714,023 shares

 

 



 

HELEN OF TROY LIMITED AND SUBSIDIARIES

 

INDEX – FORM 10-Q

 

 

 

 

 

Page

PART I.

 

FINANCIAL INFORMATION

 

 

 

 

 

 

 

 

 

Item 1.

Financial Statements

 

 

 

 

 

 

 

 

 

 

 

Consolidated Condensed Balance Sheets (unaudited)

 

 

 

 

 

as of November 30, 2010 and February 28, 2010

 

3

 

 

 

 

 

 

 

 

 

Consolidated Condensed Statements of Income (unaudited)

 

 

 

 

 

for the Three- and Nine-Months Ended

 

 

 

 

 

November 30, 2010 and November 30, 2009

 

4

 

 

 

 

 

 

 

 

 

Consolidated Condensed Statements of Cash Flows (unaudited)

 

 

 

 

 

for the Nine Months Ended

 

 

 

 

 

November 30, 2010 and November 30, 2009

 

5

 

 

 

 

 

 

 

 

 

Notes to Consolidated Condensed Financial Statements (unaudited)

 

6

 

 

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition

 

 

 

 

 

and Results of Operations

 

25

 

 

 

 

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

41

 

 

 

 

 

 

 

 

Item 4.

Controls and Procedures

 

46

 

 

 

 

 

 

PART II.

 

OTHER INFORMATION

 

 

 

 

 

 

 

 

 

Item 1.

Legal Proceedings

 

47

 

 

 

 

 

 

 

 

Item 1A.

Risk Factors

 

47

 

 

 

 

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

47

 

 

 

 

 

 

 

 

Item 6.

Exhibits

 

47

 

 

 

 

 

 

 

 

Signatures

 

48

 

2



 

PART I.   FINANCIAL INFORMATION

 

ITEM 1.   FINANCIAL STATEMENTS

 

HELEN OF TROY LIMITED AND SUBSIDIARIES

Consolidated Condensed Balance Sheets (unaudited)

(in thousands, except shares and par value)

 

 

November 30,

 

February 28,

 

 

 

2010

 

2010

 

 

 

 

 

 

 

Assets

 

 

 

 

 

Asset, current:

 

 

 

 

 

Cash and cash equivalents

 

$

70,623

 

$

110,208

 

Derivative assets, current

 

556

 

795

 

Receivables - principally trade, less allowances of $3,834 and $3,346

 

152,414

 

109,722

 

Inventory, net

 

152,312

 

124,021

 

Prepaid expenses

 

4,337

 

2,485

 

Income taxes receivable

 

1,618

 

597

 

Deferred tax assets, net

 

11,936

 

11,526

 

Total assets, current

 

393,796

 

359,354

 

 

 

 

 

 

 

Property and equipment, net of accumulated depreciation of $63,400 and $58,464

 

78,991

 

82,113

 

Goodwill

 

201,542

 

185,937

 

Other intangible assets, net of accumulated amortization of $32,729 and $33,449

 

218,417

 

177,124

 

Other assets, net of accumulated amortization of $3,997 and $3,825

 

30,688

 

30,205

 

Total assets

 

$

923,434

 

$

834,733

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Liabilities, current:

 

 

 

 

 

Accounts payable, principally trade

 

$

39,210

 

$

35,005

 

Accrued expenses and other current liabilities

 

82,068

 

67,289

 

Long-term debt, current maturities

 

53,000

 

3,000

 

Total liabilities, current

 

174,278

 

105,294

 

 

 

 

 

 

 

Deferred compensation liability

 

4,110

 

3,758

 

Other liabilities, noncurrent

 

715

 

75

 

Deferred tax liabilities, net

 

1,441

 

1,202

 

Long-term debt, excluding current maturities

 

78,000

 

131,000

 

Liability for uncertain tax positions

 

1,326

 

2,562

 

Derivative liabilities, noncurrent

 

7,621

 

7,070

 

Total liabilities

 

267,491

 

250,961

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued

 

-   

 

-   

 

Common stock, $0.10 par. Authorized 50,000,000 shares; 30,656,277 and 30,571,813 shares issued and outstanding

 

3,065

 

3,057

 

Additional paid in capital

 

125,393

 

120,761

 

Accumulated other comprehensive loss

 

(8,446

)

(8,574

)

Retained earnings

 

535,931

 

468,528

 

Total stockholders’ equity

 

655,943

 

583,772

 

Total liabilities and stockholders’ equity

 

$

923,434

 

$

834,733

 

 

See accompanying notes to consolidated condensed financial statements.

 

3



 

HELEN OF TROY LIMITED AND SUBSIDIARIES

Consolidated Condensed Statements of Income (unaudited)

(in thousands, except per share data)

 

 

Three Months Ended November 30,

 

Nine Months Ended November 30,

 

 

 

2010

 

2009

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

Sales revenue, net

 

$

205,001

 

$

189,399

 

$

539,977

 

$

495,465

 

Cost of goods sold

 

112,256

 

105,877

 

294,529

 

284,540

 

Gross profit

 

92,745

 

83,522

 

245,448

 

210,925

 

 

 

 

 

 

 

 

 

 

 

Selling, general, and administrative expense

 

61,205

 

53,658

 

163,020

 

141,230

 

Operating income before impairment

 

31,540

 

29,864

 

82,428

 

69,695

 

 

 

 

 

 

 

 

 

 

 

Asset impairment charges

 

-     

 

-     

 

501

 

900

 

Operating income

 

31,540

 

29,864

 

81,927

 

68,795

 

 

 

 

 

 

 

 

 

 

 

Nonoperating income (expense), net

 

156

 

125

 

490

 

927

 

Interest expense

 

(2,081

)

(2,146

)

(6,377

)

(8,192

)

Income before income taxes

 

29,615

 

27,843

 

76,040

 

61,530

 

 

 

 

 

 

 

 

 

 

 

Income tax expense (benefit):

 

 

 

 

 

 

 

 

 

Current

 

2,191

 

2,589

 

7,365

 

3,887

 

Deferred

 

361

 

521

 

(248

)

2,490

 

Net income

 

$

27,063

 

$

24,733

 

$

68,923

 

$

55,153

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.88

 

$

0.81

 

$

2.25

 

$

1.83

 

Diluted

 

$

0.86

 

$

0.80

 

$

2.20

 

$

1.79

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock used in computing net earnings per share:

 

 

 

 

 

 

 

 

 

Basic

 

30,644

 

30,357

 

30,640

 

30,110

 

Diluted

 

31,297

 

31,047

 

31,293

 

30,848

 

 

See accompanying notes to consolidated condensed financial statements.

 

4



 

HELEN OF TROY LIMITED AND SUBSIDIARIES

Consolidated Condensed Statements of Cash Flows (unaudited)

(in thousands)

 

 

Nine Months Ended November 30,

 

 

 

2010

 

2009

 

 

 

 

 

 

 

Net cash provided by operating activities:

 

 

 

 

 

Net income

 

$

68,923

 

$

55,153

 

Adjustments to reconcile net income to net cash provided by operating activities

 

 

 

 

 

Depreciation and amortization

 

12,415

 

11,436

 

Provision for doubtful receivables

 

69

 

577

 

Share-based compensation

 

1,547

 

1,264

 

Intangible asset impairment charges

 

501

 

900

 

Loss on the sale of property and equipment

 

50

 

33

 

Realized and unrealized gain on investments

 

-    

 

(421

)

Deferred income taxes and tax credits

 

(324

)

2,427

 

Changes in operating assets and liabilities, net of effects of acquisition of businesses:

 

 

 

 

 

Receivables

 

(34,172

)

(41,860

)

Inventories

 

(23,404

)

40,023

 

Prepaid expenses

 

(1,460

)

(1,329

)

Other assets

 

(765

)

(397

)

Accounts payable

 

(901

)

3,789

 

Accrued expenses and other current liabilities

 

13,214

 

24,837

 

Accrued income taxes

 

(2,094

)

1,497

 

Net cash provided by operating activities

 

33,599

 

97,929

 

 

 

 

 

 

 

Net cash used in investing activities:

 

 

 

 

 

Capital, license, trademark, and other intangible expenditures

 

(3,032

)

(3,303

)

Proceeds from the sale of property and equipment

 

63

 

44

 

Proceeds from sale of investments

 

300

 

1,141

 

Payments to acquire businesses

 

(69,000

)

(60,000

)

Net cash used in investing activities

 

(71,669

)

(62,118

)

 

 

 

 

 

 

Net cash used in financing activities:

 

 

 

 

 

Repayment of long-term debt

 

(3,000

)

(78,000

)

Proceeds from exercise of stock options, employee stock purchases and excess tax benefits

 

3,284

 

6,059

 

Payment of tax obligations resulting from cashless option exercise

 

-   

 

(7,166

)

Payments for repurchases of common stock

 

(1,799

)

(419

)

Net cash used in financing activities

 

(1,515

)

(79,526

)

Net decrease in cash and cash equivalents

 

(39,585

)

(43,715

)

Cash and cash equivalents, beginning balance

 

110,208

 

102,675

 

Cash and cash equivalents, ending balance

 

$

70,623

 

$

58,960

 

 

 

 

 

 

 

Supplemental cash flow information:

 

 

 

 

 

Interest paid

 

$

6,208

 

$

8,673

 

Income taxes paid, net of refunds

 

$

9,389

 

$

(2,194

)

Value of common stock received as exercise price of options

 

$

-

 

$

23,261

 

 

See accompanying notes to consolidated condensed financial statements.

 

5



 

HELEN OF TROY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (unaudited)

November 30, 2010

 

Note 1 - Basis of Presentation

 

In our opinion, the accompanying consolidated condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly our consolidated financial position as of November 30, 2010 and February 28, 2010, and the results of our consolidated operations for the three- and nine-month periods ended November 30, 2010 and 2009. The same accounting policies are followed in preparing quarterly financial data as are followed in preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2010, and our other reports on file with the Securities and Exchange Commission (“SEC”).  In some cases, we have provided additional information for prior periods in the accompanying notes to consolidated condensed financial statements to conform to the current period’s presentation.  In this report and the accompanying consolidated condensed financial statements and notes, unless the context suggests otherwise or otherwise indicated, references to “the Company,” “our Company,” “Helen of Troy,” “we,” “us” or “our” refer to Helen of Troy Limited and its subsidiaries.  We refer to the Company’s common shares, par value $0.10 per share, as “common stock.”

 

Product and service names mentioned in this report are used for identification purposes only and may be protected by trademarks, trade names, services marks and/or other intellectual property rights of the Company and/or other parties in the United States and/or other jurisdictions.  The absence of a specific attribution in connection with any such mark does not constitute a waiver of any such right.  All trademarks, trade names, service marks and logos referenced herein belong to their respective companies.

 

Note 2 – New Accounting Pronouncements

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the “FASB”) or other standards setting bodies that are adopted by the Company as of the specified effective date.  Unless otherwise discussed, the Company’s management believes that the impact of recently issued standards that are not yet effective will not have a material impact on its consolidated financial position, results of operations and cash flows upon adoption.

 

Note 3 – Litigation

 

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations, or liquidity.

 

Note 4 – Earnings per Share

 

Basic earnings per share is computed based upon the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed based upon the weighted average number of shares of common stock outstanding during the period plus the effect of dilutive securities.   Our dilutive securities consist entirely of outstanding options for common stock that were “in-the-money,” meaning that the exercise price of the options was less than the average market price of our common stock during the period reported.  “Out-of-the-money” options are outstanding options to purchase common stock that were excluded from the computation of earnings per share because the exercise price of the options was greater than the average market price of our common stock during the period reported.  Thus, their effect would be antidilutive.

 

6



 

The effect of dilutive securities was approximately 652,600 and 653,900 shares of common stock for the three- and nine-month periods ended November 30, 2010, respectively, and 690,600 and 737,400 shares of common stock for the three- and nine-month periods ended November 30, 2009, respectively.   Options for common stock that were antidilutive totaled approximately 527,700 and 620,500 for the three- and nine-month periods ended November 30, 2010, respectively, and 1,203,400 and 1,521,400 for the three- and nine-month periods ended November 30, 2009, respectively.

 

Note 5 – Comprehensive Income

 

The components of comprehensive income, net of tax, for the periods covered by this report are as follows:

 

COMPONENTS OF COMPREHENSIVE INCOME

(in thousands)

 

 

Three Months Ended November 30,

 

Nine Months Ended November 30,

 

 

 

2010

 

2009

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

27,063

 

$

24,733

 

$

68,923

 

$

55,153

 

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

 

Cash flow hedges - interest rate swaps, net of tax (1)

 

860

 

(828

)

118

 

355

 

Cash flow hedges - foreign currency, net of tax (2)

 

(412

)

66

 

17

 

(801

)

Unrealized gain (loss) - auction rate securities, net of tax (3)

 

(4

)

(59

)

(7

)

311

 

Comprehensive income, net of tax

 

$

27,507

 

$

23,912

 

$

69,051

 

$

55,018

 

 

The components of accumulated other comprehensive loss, net of tax, for the periods covered by our consolidated condensed balance sheets are as follows:

 

COMPONENTS OF ACCUMULATED OTHER COMPREHENSIVE LOSS

(in thousands)

 

 

November 30,

 

February 28,

 

 

 

2010

 

2010

 

 

 

 

 

 

 

Unrealized holding losses on cash flow hedges - interest rate swaps, net of tax (1)

 

$

(7,816

)

$

(7,934

)

Unrealized holding gains on cash flow hedges - foreign currency, net of tax (2)

 

609

 

592

 

Temporary impairment loss on auction rate securities, net of tax (3)

 

(1,239

)

(1,232

)

Total accumulated other comprehensive loss

 

$

(8,446

)

$

(8,574

)

 

(1)

The change in unrealized loss on interest rate swap cash flow hedges is recorded net of tax expense (benefits) of $0.44 and $0.06 million for the three- and nine-month periods ended November 30, 2010, respectively, and ($0.43) and $0.18 million for the three- and nine-month periods ended November 30, 2009, respectively. The unrealized holding loss on interest rate swap cash flow hedges included in accumulated other comprehensive loss includes net deferred tax benefits of $4.03 and $4.09 million at November 30, 2010 and February 28, 2010, respectively.

 

 

(2)

The change in unrealized gain (loss) on foreign currency cash flow and ordinary hedges is recorded net of tax expense (benefits) of ($0.21) and $0.02 million for the three- and nine-month periods ended November 30, 2010, respectively, and $0.03 and ($0.34) million for the three- and nine-month periods ended November 30, 2009, respectively. The unrealized holding gain on foreign currency cash flow hedges included in accumulated other comprehensive loss, includes net deferred tax expense of $0.26 and $0.24 million at November 30, 2010 and February 28, 2010, respectively.

 

 

(3)

The change in temporary impairment loss on auction rate securities is recorded net of tax expense (benefits) of $0.00 for both the three- and nine-month periods ended November 30, 2010, and ($0.03) and $0.16 million for the three- and nine-month periods ended November 30, 2009, respectively. The temporary impairment loss on auction rate securities included in accumulated other comprehensive loss, includes net deferred tax benefits of ($0.64) and ($0.63) million at November 30, 2010 and February 28, 2010, respectively.

 

7



 

Note 6 – Segment Information

 

In the tables that follow, we present two segments: Personal Care and Housewares.  Our Personal Care segment’s products include hair dryers, straighteners, curling irons, hairsetters, shavers, mirrors, hot air brushes, home hair clippers and trimmers, paraffin baths, massage cushions, footbaths, body massagers, brushes, combs, hair accessories, liquid and aerosol hair styling products, men’s fragrances, men’s and women’s antiperspirants and deodorants, liquid and bar soaps, shampoos, hair treatments, foot powder, body powder and skin care products.  Our Housewares segment reports the operations of the OXO family of brands whose products include kitchen tools, cutlery, bar and wine accessories, household cleaning tools, food storage containers, tea kettles, trash cans, storage and organization products, hand tools, gardening tools, kitchen mitts and trivets, barbeque tools, rechargeable lighting products and baby-toddler products.  We use third-party manufacturers to produce our goods.  Both our Personal Care and Housewares segments sell their products primarily through mass merchandisers, drugstore chains, warehouse clubs, catalogs, grocery stores and specialty stores.  In addition, the Personal Care segment sells through beauty supply retailers and wholesalers.

 

The following tables contain segment information for the periods covered by our consolidated condensed statements of income:

 

THREE MONTHS ENDED NOVEMBER 30, 2010 AND 2009

(in thousands)

 

 

Personal

 

 

 

 

 

November 30, 2010

 

Care

 

Housewares

 

Total

 

 

 

 

 

 

 

 

 

Sales revenue, net

 

$

146,506

 

$

58,495

 

$

205,001

 

Operating income before impairment

 

18,816

 

12,724

 

31,540

 

Asset impairment charges

 

-    

 

-    

 

-    

 

Operating income

 

18,816

 

12,724

 

31,540

 

Capital, license, trademark and other intangible expenditures

 

299

 

734

 

1,033

 

Depreciation and amortization

 

2,674

 

1,435

 

4,109

 

 

 

 

 

 

 

 

 

 

 

Personal

 

 

 

 

 

November 30, 2009

 

Care

 

Housewares

 

Total

 

 

 

 

 

 

 

 

 

Sales revenue, net

 

$

134,206

 

$

55,193

 

$

189,399

 

Operating income before impairment

 

16,591

 

13,273

 

29,864

 

Asset impairment charges

 

-    

 

-    

 

-    

 

Operating income

 

16,591

 

13,273

 

29,864

 

Capital, license, trademark and other intangible expenditures

 

982

 

740

 

1,722

 

Depreciation and amortization

 

2,131

 

1,372

 

3,503

 

 

NINE MONTHS ENDED NOVEMBER 30, 2010 AND 2009

(in thousands)

 

 

Personal

 

 

 

 

 

November 30, 2010

 

Care

 

Housewares

 

Total

 

 

 

 

 

 

 

 

 

Sales revenue, net

 

$

377,853

 

$

162,124

 

$

539,977

 

Operating income before impairment

 

47,142

 

35,286

 

82,428

 

Asset impairment charges

 

501

 

-    

 

501

 

Operating income

 

46,641

 

35,286

 

81,927

 

Capital, license, trademark and other intangible expenditures

 

1,220

 

1,812

 

3,032

 

Depreciation and amortization

 

7,904

 

4,511

 

12,415

 

 

 

 

 

 

 

 

 

 

 

Personal

 

 

 

 

 

November 30, 2009

 

Care

 

Housewares

 

Total

 

 

 

 

 

 

 

 

 

Sales revenue, net

 

$

347,018

 

$

148,447

 

$

495,465

 

Operating income before impairment

 

36,503

 

33,192

 

69,695

 

Asset impairment charges

 

900

 

-    

 

900

 

Operating income

 

35,603

 

33,192

 

68,795

 

Capital, license, trademark and other intangible expenditures

 

1,264

 

2,039

 

3,303

 

Depreciation and amortization

 

7,329

 

4,107

 

11,436

 

 

8



 

We compute operating income for each segment based on net sales revenue, less cost of goods sold, selling, general and administrative expense (“SG&A”), and any impairment charges associated with the segment. The SG&A used to compute each segment’s operating income includes SG&A directly associated with the segment, plus overhead expenses that are allocable to the segment.  We do not allocate nonoperating income (expense), interest expense or income taxes to operating segments.  The following tables contain identifiable assets allocable to each segment for the periods covered by our consolidated condensed balance sheets:

 

IDENTIFIABLE ASSETS AT NOVEMBER 30, 2010 AND FEBRUARY 28, 2010

(in thousands)

 

 

Personal

 

 

 

 

 

 

 

Care

 

Housewares

 

Total

 

 

 

 

 

 

 

 

 

November 30, 2010

 

$

558,058

 

$

365,376

 

$

923,434

 

February 28, 2010

 

483,106

 

351,627

 

834,733

 

 

Note 7 – Property and Equipment

 

A summary of property and equipment is as follows:

 

PROPERTY AND EQUIPMENT

(in thousands)

 

 

Estimated

 

 

 

 

 

 

 

Useful Lives

 

November 30,

 

February 28,

 

 

 

(Years)

 

2010

 

2010

 

 

 

 

 

 

 

 

 

Land

 

-  

 

 

$

9,073

 

$

9,073

 

Building and improvements

 

10 - 40

 

 

65,059

 

65,117

 

Computer and other equipment

 

3 - 10

 

 

46,529

 

46,088

 

Tools, dies and molds

 

1 - 3

 

 

11,489

 

9,573

 

Transportation equipment

 

3 - 5

 

 

153

 

240

 

Furniture and fixtures

 

5 - 15

 

 

8,601

 

8,532

 

Construction in process

 

-  

 

 

1,487

 

1,954

 

Property and equipment, gross

 

 

 

 

142,391

 

140,577

 

Less accumulated depreciation

 

 

 

 

(63,400

)

(58,464

)

Property and equipment, net

 

 

 

 

$

78,991

 

$

82,113

 

 

Depreciation expense was $1.97 and $6.07 million for the three- and nine-month periods ended November 30, 2010, respectively, and $1.95 and $6.89 million for the three- and nine-month periods ended November 30, 2009, respectively.

 

We lease certain facilities, equipment and vehicles under operating leases, which expire at various dates through fiscal 2019.  Certain leases contain escalation clauses and renewal or purchase options.  Rent expense related to our operating leases was $0.60 and $1.62 million for the three- and nine-month periods ended November 30, 2010, respectively, and $0.56 and $1.71 million for the three- and nine-month periods ended November 30, 2009, respectively.

 

9


 

 


 

Note 8 – Intangible Assets

 

Annual Impairment Testing in the First Quarter of Fiscal 2011 - The Company performed its annual evaluation of goodwill and indefinite-lived intangible assets for impairment during the first quarter of fiscal 2011.  As a result of its testing, the Company recorded a non-cash impairment charge of $0.50 million ($0.49 million after tax).  The charge was related to an indefinite-lived trademark in our Personal Care segment that was written down to its fair value, determined on the basis of future discounted cash flows using the relief from royalty method.

 

Annual Impairment Testing in the First Quarter of Fiscal 2010 - The Company performed its annual evaluation of goodwill and indefinite-lived intangible assets for impairment during the first quarter of fiscal 2010.  As a result of its testing, the Company concluded no further impairments had occurred since the fourth quarter of fiscal 2009, when interim testing was performed and a total non-cash impairment charge of $99.51 million ($99.06 million after tax) was recorded.

 

A summary of the carrying amounts and associated accumulated amortization for all intangible assets by operating segment is as follows:

 

GOODWILL AND INTANGIBLE ASSETS

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

November 30, 2010

 

February 28, 2010

 

 

 

Gross

 

Cumulative

 

 

 

 

 

 

 

Gross

 

Cumulative

 

 

 

 

 

 

 

 

Carrying

 

Goodwill

 

Accumulated

 

Net Book

 

 

 

Carrying

 

Goodwill

 

Accumulated

 

Net Book

 

Description / Life

 

 

Amount

 

Impairments

 

Amortization

 

Value

 

 

 

Amount

 

Impairments

 

Amortization

 

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Personal Care:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

$

81,901

 

$

(46,490

)

$

-

 

$

35,411

 

 

 

$

66,296

 

$

(46,490

)

$

-

 

$

19,806

 

Trademarks - indefinite

 

 

76,203

 

 

 

-

 

76,203

 

 

 

53,054

 

-

 

-

 

53,054

 

Trademarks - finite

 

 

338

 

-

 

(249

)

89

 

 

 

338

 

-

 

(245

)

93

 

Licenses - indefinite

 

 

10,300

 

-

 

-

 

10,300

 

 

 

10,300

 

-

 

-

 

10,300

 

Licenses - finite

 

 

19,564

 

-

 

(15,314

)

4,250

 

 

 

24,196

 

-

 

(19,495

)

4,701

 

Other intangibles - finite

 

 

49,401

 

-

 

(7,560

)

41,841

 

 

 

26,286

 

-

 

(4,049

)

22,237

 

Total Personal Care

 

 

237,707

 

(46,490

)

(23,123

)

168,094

 

 

 

180,470

 

(46,490

)

(23,789

)

110,191

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Housewares:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

166,131

 

-

 

-

 

166,131

 

 

 

166,131

 

-

 

-

 

166,131

 

Trademarks - indefinite

 

 

75,554

 

-

 

-

 

75,554

 

 

 

75,554

 

-

 

-

 

75,554

 

Other intangibles - finite

 

 

19,786

 

-

 

(9,606

)

10,180

 

 

 

20,845

 

-

 

(9,660

)

11,185

 

Total Housewares

 

 

261,471

 

-

 

(9,606

)

251,865

 

 

 

262,530

 

-

 

(9,660

)

252,870

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

$

499,178

 

$

(46,490

)

$

(32,729

)

$

419,959

 

 

 

$

443,000

 

$

(46,490

)

$

(33,449

)

$

363,061

 

 

Intangible asset activity for the nine month period ended November 30, 2010 was as follows:

 

·                  Personal Care segment: During the three month period ended May 31, 2010, we recorded $63.13 million of intangible assets, net of certain acquisition adjustments, in connection with our acquisition of the Pert Plus and Sure products business (as discussed further in Note 9), and a non-cash impairment charge of $0.50 million against the carrying value of an indefinite-lived trademark.  During the three- and nine-month periods ended November 30, 2010, we recorded $0.00 and $0.24 million, respectively, in acquisition adjustment reductions related to the Pert Plus and Sure products business. In addition, during nine month period ended November 30, 2010, we recorded adjustments to remove certain fully amortized license agreements and other intangibles with a combined gross carrying value of $5.39 million.

 

·                  Housewares segment:  During the three- and nine-month periods ended November 30, 2010, we recorded adjustments to remove certain fully amortized patents having a gross carrying value of $0.05 and $0.91 million, respectively. During the three- and nine-month periods ended November 30, 2010, we recorded

 

10



 

adjustments to remove certain fully amortized other intangibles with a gross carrying value of $0.00 and  $0.59 million, respectively.  We also recorded new patent development costs of $0.15 and $0.45 million for the three- and nine-month periods ended November 30, 2010, respectively.

 

The following table summarizes the amortization expense attributable to intangible assets for the three- and nine-month periods ended November 30, 2010 and 2009, as well as our estimated amortization expense for the fiscal years ending the last day of each February 2011 through 2016.

 

AMORTIZATION OF INTANGIBLE ASSETS

 

(in thousands)

 

 

 

Aggregate Amortization Expense

For the three months ended

 

 

 

November 30, 2010

 

$

2,086

 

November 30, 2009

 

$

1,496

 

 

 

 

 

Aggregate Amortization Expense

 

 

 

For the nine months ended

 

 

 

November 30, 2010

 

$

6,177

 

November 30, 2009

 

$

4,281

 

 

 

 

 

Estimated Amortization Expense

 

 

 

For the fiscal years ended

 

 

 

February 2011

 

$

8,195

 

February 2012

 

$

8,053

 

February 2013

 

$

8,020

 

February 2014

 

$

7,555

 

February 2015

 

$

7,479

 

February 2016

 

$

7,295

 

 

11



 

NOTE 9 - Acquisitions

 

Pert Plus and Sure Acquisition - On March 31, 2010, we completed the acquisition of certain assets and liabilities of the Pert Plus hair care and Sure antiperspirant and deodorant businesses from Innovative Brands, LLC for a net purchase price of $69.00 million, which we paid with cash on hand.  Net assets acquired consist principally of accounts receivable, finished goods inventories, prepaid expenses, goodwill, patents, trademarks, tradenames, product design specifications, production know-how, certain fixed assets, distribution rights and customer lists, less certain product related operating accruals and other current liabilities.  We market Pert Plus and Sure products primarily into retail trade channels.

 

We have accounted for the acquisition as the purchase of a business and have recorded the excess purchase price as goodwill. All of the goodwill is held in jurisdictions that do not allow deductions for tax purposes. We have completed our analysis of the economic lives of all the assets acquired and determined the appropriate allocation of the initial purchase price. We assigned the acquired trademarks indefinite economic lives and will amortize the customer list and patent rights over expected average lives of approximately 8.2 and 7.5 years, respectively.  For the customer list, we used our historical attrition rates to assign an expected life.  For patent rights, we used the underlying non-renewable term of a royalty free license we acquired for the use of patented formulas in certain Pert Plus and Sure products. The trademarks acquired are considered to have indefinite lives that are not subject to amortization.  The goodwill arising from the Pert Plus and Sure acquisition consists largely of the distribution network, marketing synergies and economies of scale expected to occur from the addition of the new product line.

 

The following schedule presents the acquisition date fair value of the net assets of Pert Plus and Sure:

 

PERT PLUS AND SURE - NET ASSETS ACQUIRED ON MARCH 31, 2010

 

(in thousands)

 

 

 

Receivables

 

$

8,589

 

Inventory

 

4,887

 

Prepaid expenses

 

392

 

Tools, dies and molds

 

730

 

Goodwill

 

15,845

 

Trademarks

 

23,650

 

Patent rights

 

2,600

 

Customer list

 

21,275

 

Total assets acquired

 

77,968

 

Less: Accounts payable and other current liabilities assumed or recorded at acquisition

 

(8,968

)

Net assets acquired

 

$

69,000

 

 

The fair values of the intangible assets acquired were estimated by applying income and market approaches. These fair value measurements were based on significant inputs that are not observable in the market and, therefore, represent Level 3 measurements as defined under U.S. generally accepted accounting principles (“GAAP”). Key assumptions included various discount rates based upon a 15.8 percent weighted average cost of capital, royalty rates of 5 percent used in the determination of trademark values and customer attrition rates of 11.5 percent per year used in the determination of customer list values.

 

12



 

The impact of the Pert Plus and Sure acquisition on the Company’s consolidated condensed statements of income from the acquisition date through the three- and nine-month periods ended November 30, 2010 was as follows:

 

PERT PLUS AND SURE - IMPACT ON CONSOLIDATED CONDENSED STATEMENTS OF INCOME

March 31, 2010 (Acquisition Date) through November 30, 2010

(in thousands, except per share data)

 

 

 

 

Periods Ended November 30, 2010

 

 

 

 

Three Months

 

Nine Months

 

 

 

 

 

 

 

 

Sales revenue, net

 

 

$

17,593

 

$

48,422

 

Net income

 

 

3,469

 

9,504

 

 

 

 

 

 

 

 

Earning per share impact

 

 

 

 

 

 

Basic

 

 

$

0.11

 

$

0.31

 

Diluted

 

 

$

0.11

 

$

0.30

 

 

The following supplemental pro forma information presents the Company’s financial results as if the Pert Plus and Sure acquisition had occurred as of the beginning of each of the fiscal periods presented.  This supplemental pro forma information has been prepared for comparative purposes and would not necessarily indicate what may have occurred if the acquisition had been completed on March 1, 2010 or 2009, and this information is not intended to be indicative of future results.

 

PERT PLUS AND SURE - PRO FORMA IMPACT ON CONSOLIDATED CONDENSED STATEMENTS OF INCOME

As if the Acquisition Had Been Completed at the Beginning of Each Period

(in thousands, except per share data)

 

 

Three Months Ended November 30,

 

Nine Months Ended November 30,

 

 

 

2010

 

2009

 

 

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales revenue, net

 

 

$

205,001

 

$

206,061

 

 

 

$

545,608

 

$

549,400

 

Net income

 

 

27,063

 

28,252

 

 

 

70,020

 

66,477

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earning per share impact

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

$

0.88

 

$

0.93

 

 

 

$

2.29

 

$

2.21

 

Diluted

 

 

$

0.86

 

$

0.91

 

 

 

$

2.24

 

$

2.15

 

 

Infusium 23 Acquisition - On March 31, 2009, we completed the acquisition of certain assets, trademarks, customer lists, distribution rights, patents, goodwill and formulas for Infusium 23 (“Infusium”) hair care products from The Procter & Gamble Company for a purchase price of $60 million, which we paid with cash on hand.  We accounted for the acquisition as the purchase of a business and recorded the excess purchase price as goodwill. All of this goodwill is held in jurisdictions that do not allow deductions for tax purposes. We completed our analysis of the economic lives of all the assets acquired and determined the appropriate allocation of the initial purchase price. We assigned the acquired trademarks indefinite economic lives and will amortize the customer list and patent rights over expected lives of 9.0 and 7.5 years, respectively.  For the customer list, we used our historical attrition rates to assign an expected life.  For patent rights, we used the underlying non-renewable term of a royalty free license we acquired for the use of patented formulas in certain Infusium products. The trademarks acquired are considered to have indefinite lives that are not subject to amortization.  The goodwill arising from the Infusium acquisition consists largely of the distribution network, marketing synergies and economies of scale expected to occur from the addition of the new product line. The following schedule presents the acquisition date fair value of the net assets of Infusium:

 

INFUSIUM 23 - BRAND ASSETS ACQUIRED ON MARCH 31, 2009

 

(in thousands)

 

 

 

Goodwill

 

$

19,700

 

Trademarks

 

18,700

 

Patent rights

 

600

 

Customer list

 

21,000

 

Total assets acquired

 

$

60,000

 

 

13



 

Note 10 – Short Term Debt

 

In June 2004, we entered into a Revolving Line of Credit Agreement (the “2004 RCA”) with Bank of America, N.A. that provides for a total revolving commitment of up to $50 million.  Borrowings under the 2004 RCA accrued interest at a “Base Rate” plus a margin of 0.25 to 0.75 percent based on the Leverage Ratio (as defined in the 2004 RCA) at the time of borrowing.  The base rate is equal to the highest of the Federal Funds Rate (as defined in the 2004 RCA) plus 0.50 percent, Bank of America’s prime rate, or the one month LIBOR rate plus 1 percent.  Alternatively, if we elected, borrowings accrued interest based on the respective 1, 2, 3, or 6-month LIBOR rate plus a margin of 1.25 to 1.75 percent based upon the Leverage Ratio at the time of the borrowing. We incured loan commitment fees at a rate of 0.20 percent per annum on the unused balance of the 2004 RCA and letter of credit fees at a rate of 1.25 percent per annum on the face value of any letter of credit. Outstanding letters of credit reduced the borrowing availability dollar for dollar.  As of November 30, 2010, there were no revolving loans and $0.20 million of open letters of credit outstanding against this facility.

 

The 2004 RCA contained certain covenants and formulas that limited our outstanding indebtedness from all sources (less unrestricted cash on hand in excess of $15 million) to no more than 3.0 times the latest twelve months’ trailing EBITDA. The 2004 RCA was unconditionally guaranteed, on a joint and several basis, by the parent company, Helen of Troy Limited and certain subsidiaries.  As with our other debt agreements, the 2004 RCA restricted us, among other things, from incurring liens on any of our properties, except under certain conditions, and limited our ability to repurchase shares of our common stock.  As of November 30, 2010, we were in compliance with the terms of the 2004 RCA and our other debt agreements.

 

On December 31, 2010, we terminated the 2004 RCA and, in connection with our acquisition of Kaz, Inc. (“Kaz”), we entered into a new Revolving Line of Credit Agreement (the “2010 RCA”) with Bank of America, N.A.  We also entered into a Term Loan Credit Agreement with Bank of America, N.A. on December 30, 2010.  For further information about these subsequent events, see Note 18.

 

Note 11 – Accrued Expenses and Current Liabilities

 

A summary of accrued expenses and other current liabilities is as follows:

 

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

(in thousands)

 

 

November 30,

 

February 28,

 

 

 

2010

 

2010

 

 

 

 

 

 

 

Accrued defectives, discounts and allowances

 

$

26,579

 

$

20,758

 

Accrued compensation

 

16,802

 

17,888

 

Accrued advertising

 

12,322

 

6,862

 

Accrued interest

 

1,337

 

1,339

 

Accrued royalties

 

4,716

 

3,612

 

Accrued professional fees

 

1,486

 

730

 

Accrued benefits and payroll taxes

 

1,696

 

1,170

 

Accrued freight

 

2,545

 

1,398

 

Accrued property, sales and other taxes

 

3,959

 

879

 

Derivative liabilities, current

 

4,222

 

4,951

 

Other

 

6,404

 

7,702

 

Total accrued expenses and other current liabilities

 

$

82,068

 

$

67,289

 

 

14



 

Note 12 – Income Taxes

 

United States Income Taxes - In April 2010, the IRS concluded its audit of the Company’s 2007 and 2008 tax returns.  No adjustments were made to either year’s tax returns.

 

Income Tax Provisions - We must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments must be used in the calculation of certain tax assets and liabilities because of differences in the timing of recognition of revenue and expense for tax and financial statement purposes.  We must assess the likelihood that we will be able to recover our deferred tax assets.  If recovery is not likely, we must increase our provision for taxes by recording a valuation allowance against the deferred tax assets that we estimate will not ultimately be recoverable. As changes occur in our assessments regarding our ability to recover our deferred tax assets, our tax provision is increased in any period in which we determine that the recovery is not probable.

 

In 1994, we engaged in a corporate restructuring that, among other things, resulted in a greater portion of our income not being subject to taxation in the U.S.  If such income were subject to U.S. federal income taxes, our effective income tax rate would increase materially. Future actions by taxing authorities may result in tax liabilities that are significantly higher than the reserves established which could have a material adverse effect on our consolidated results of operations or cash flows.  Additionally, the U.S. government is currently considering several alternative proposed changes in the tax law that, if enacted, could increase our overall effective tax rate.

 

Note 13 – Long-Term Debt

 

A summary of long-term debt is as follows:

 

LONG-TERM DEBT

(dollars in thousands)

 

 

Original

 

 

 

 

 

 

 

 

 

 

 

Interest

 

Interest

 

 

 

November 30,

 

February 28,

 

 

 

Borrowed

 

Rates

 

Matures

 

2010

 

2010

 

 

 

 

 

 

 

 

 

 

 

 

 

$15 million unsecured Senior Note payable at a fixed interest rate of 7.24%. Interest payable quarterly. Annual principal payments of $3 million began in July 2008.

 

07/97

 

7.24%

 

07/12

 

$

6,000

 

$

9,000

 

 

 

 

 

 

 

 

 

 

 

 

 

$50 million unsecured floating interest rate 7 year Senior Notes. Interest set and payable quarterly at three-month LIBOR plus 85 basis points. Principal is due at maturity. Notes can be prepaid without penalty. (1)

 

06/04

 

5.89%

 

06/11

 

50,000

 

50,000

 

 

 

 

 

 

 

 

 

 

 

 

 

$75 million unsecured floating interest rate 10 year Senior Notes. Interest set and payable quarterly at three-month LIBOR plus 90 basis points. Principal is due at maturity. Notes can be prepaid without penalty. (1)

 

06/04

 

6.01%

 

06/14

 

75,000

 

75,000

 

Total long-term debt

 

 

 

 

 

 

 

131,000

 

134,000

 

Less current maturities of long-term debt

 

 

 

 

 

 

 

(53,000

)

(3,000

)

Long-term debt, excluding current maturities

 

 

 

 

 

 

 

$

78,000

 

$

131,000

 

 

(1)        Floating interest rates have been hedged with interest rate swaps to effectively fix interest rates.  Additional information regarding these swaps is provided in Note 15.

 

All of our long-term debt is unconditionally guaranteed by the parent company, Helen of Troy Limited and/or certain subsidiaries on a joint and several basis.  Our debt agreements require the maintenance of certain maximum debt leverage and interest coverage ratios, specify minimum consolidated net worth levels and contain other customary covenants. Additionally, among other things, our debt agreements restrict us from incurring liens

 

15



 

on any of our properties, except under certain conditions, and limit our ability to repurchase our common stock.  As of November 30, 2010, we were in compliance with the terms of these agreements.

 

The following table contains a summary of the components of our interest expense for the periods covered by our consolidated condensed statements of income:

 

INTEREST EXPENSE

(in thousands)

 

 

Three Months Ended November 30,

 

Nine Months Ended November 30,

 

 

 

2010

 

2009

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

Interest and commitment fees

 

$

534

 

$

601  

 

$

1,704

 

$

2,917

 

Deferred finance costs

 

57

 

61  

 

171

 

272

 

Interest rate swap settlements, net

 

1,490

 

1,484  

 

4,502

 

5,003

 

Total interest expense

 

$

2,081

 

$

2,146  

 

$

6,377

 

$

8,192

 

 

16


 


 

Note 14 – Fair Value

 

The following tables present the fair value hierarchy of our financial assets and liabilities carried at fair value or measured for disclosure purposes on a recurring basis as of November 30, 2010 and February 28, 2010:

 

FAIR VALUES OF FINANCIAL ASSETS AND LIABILITIES

(in thousands)

 

 

 

 

 

Quoted Prices in

 

Significant Other

 

Significant

 

 

 

 

 

Active Markets

 

Observable

 

Unobservable

 

 

 

Fair Values at

 

for Identical Assets

 

Market Inputs

 

Inputs

 

Description

 

November 30, 2010

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

Money market accounts

 

$

15,852

 

$

15,852

 

$

-    

 

$

-    

 

Commercial paper

 

8,640

 

8,640

 

-    

 

-    

 

Auction rate securities

 

20,223

 

-    

 

-    

 

20,223

 

Foreign currency contracts

 

755

 

-    

 

755

 

-    

 

Total assets

 

$

45,470

 

$

24,492

 

$

755

 

$

20,223

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Long-term debt - fixed rate (1)

 

$

6,412

 

$

-    

 

$

6,412

 

$

-    

 

Long-term debt - floating rate (1)

 

125,000

 

-    

 

125,000

 

-    

 

Interest rate swaps

 

11,843

 

-    

 

11,843

 

-    

 

Total liabilities

 

$

143,255

 

$

-    

 

$

143,255

 

$

-    

 

 

 

 

 

 

Quoted Prices in

 

Significant Other

 

Significant

 

 

 

 

 

Active Markets

 

Observable

 

Unobservable

 

 

 

Fair Values at

 

for Identical Assets

 

Market Inputs

 

Inputs

 

Description

 

February 28, 2010

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

Money market accounts

 

$

14,099

 

$

14,099

 

$

-    

 

$

-    

 

Commercial paper

 

88,822

 

88,822

 

-    

 

-    

 

Auction rate securities

 

20,534

 

-    

 

-    

 

20,534

 

Foreign currency contracts

 

795

 

-    

 

795

 

-    

 

Total assets

 

$

124,250

 

$

102,921

 

$

795

 

$

20,534

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Long-term debt - fixed rate (1)

 

$

9,600

 

$

-    

 

$

9,600

 

$

-    

 

Long-term debt - floating rate (1)

 

125,000

 

-    

 

125,000

 

-    

 

Interest rate swaps

 

12,021

 

-    

 

12,021

 

-    

 

Total liabilities

 

$

146,621

 

$

-    

 

$

146,621

 

$

-    

 

 

 

(1)  Debt values are reported at their estimated fair values in this table, but are recorded in the accompanying consolidated condensed balance sheets at the undiscounted value of remaining principal payments due.

 

Money market accounts and commercial paper are included in cash and cash equivalents in the accompanying consolidated condensed balance sheets and are classified as Level 1 assets.

 

We classify our auction rate securities (“ARS”)  as Level 3 assets because we determine their estimated fair values with discounted cash flow models using the methodology and assumptions described in Note 10 to the consolidated financial statements contained in our latest annual report on Form 10-K.

 

17



 

We classify our fixed and floating rate debt as Level 2 liabilities because the estimation of the fair market value of debt requires the use of a discount rate based upon current market rates of interest for debt with comparable remaining terms.  Such comparable rates are considered significant other observable market inputs. The fair market value of the fixed rate debt at November 30, 2010 was computed using a discounted cash flow analysis and discount rate of 1.85 percent.  All other long-term debt has floating interest rates and its book value approximates its fair value as of the reporting date.

 

We use derivatives for hedging purposes and our derivatives are primarily foreign currency contracts and interest rate swaps. We determine the fair value of our derivative instruments based on Level 2 inputs in the fair value hierarchy.

 

The Company’s other non-financial assets include goodwill and other intangible assets, which we classify as Level 3 assets. These assets are measured at fair value on a nonrecurring basis as part of the Company’s impairment assessments and as circumstances require.

 

The table below presents a reconciliation of our ARS measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three- and nine-month periods ended November 30, 2010:

 

FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE INPUTS (Level 3)

(in thousands)

 

 

 

Periods Ended November 30, 2010

 

 

 

Three Months

 

Nine Months

 

 

 

 

 

 

 

Balance at beginning of period

 

$

20,330

 

$

20,534

 

Total gains (losses):

 

 

 

 

 

Included in other comprehensive income - unrealized

 

(7

)

(11

)

Sales at par

 

(100

)

(300

)

Balance at end of period

 

$

20,223

 

$

20,223

 

 

 

 

 

 

 

Cumulative unrealized losses relating to assets still held at the reporting date, net of taxes

 

 

 

$

(1,239

)

 

In connection with our annual impairment testing during the fiscal quarter ended May 31, 2010, we recorded a non-cash impairment charge of $0.50 million against the carrying value of indefinite-lived trademark in our Personal Care segment, which we classify as a nonrecurring Level 3 asset.  The indefinite-lived trademark was written down to its fair value of $5.60 million, as determined on the basis of future discounted cash flows using the relief from royalty method.

 

Note 15 – Financial Instruments and Risk Management

 

Foreign currency risk - Our functional currency is the U.S. Dollar. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. During the three- and nine-month periods ended November 30, 2010, approximately 16 and 13 percent, respectively, of our net sales revenue were in foreign currencies. During the three- and nine-month periods ended November 30, 2009, approximately 16 and 15 percent, respectively, of our net sales revenue were in foreign currencies. These sales were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars, Chilean Pesos, Peruvian Soles and Venezuelan Bolivares Fuertes. We make most of our inventory purchases from the Far East and use the U.S. Dollar for such purchases. In our consolidated condensed statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable,

 

18



 

deferred tax assets and deferred tax liabilities, are recognized in their respective income tax lines, and all other foreign exchange gains and losses are recognized in SG&A. For the three- and nine-month periods ended November 30, 2010, we recorded net foreign exchange gains (losses), including the impact of currency hedges, of $0.40 and $0.49 million, respectively, in SG&A and ($0.05) and $0.09 million, respectively, in income tax expense. For the three- and nine-month periods ended November 30, 2009, we recorded net foreign exchange gains (losses), including the impact of currency hedges, of $0.14 and $3.43 million, respectively, in SG&A and ($0.02) and $0.10 million, respectively, in income tax expense.

 

We have historically hedged against certain foreign currency exchange rate-risk by using a series of forward contracts designated as cash flow hedges to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar. We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes.

 

Venezuela has recently experienced currency instability driven by a highly inflationary economy, government restrictions on cash transfers out of the country and a recent devaluation.  Our method of foreign currency translation has always required us to remeasure foreign monetary assets at the current exchange rates with all exchange gains or losses recognized in our income statement.  The exchange rate we use to remeasure Venezuelan activity is currently the official exchange rate of 4.30 Bolivares Fuertes to $1.00.  At November 30, 2010, the Company included in its consolidated condensed balance sheet $3.94 million in total assets and $3.27 million in net assets from its Venezuelan operations.  Net assets are primarily working capital.  It is unclear to us whether the current restrictions on transfers of cash out of Venezuela is other than temporary; however, we believe it appropriate to classify these assets and liabilities as current items in our consolidated condensed balance sheets since they support current operations within the country.

 

Interest rate risk – Interest on our long-term debt outstanding as of November 30, 2010 is both floating and fixed. Fixed rates are in place on $6 million of Senior Notes at 7.24 percent and floating rates are in place on $125 million of Senior Notes, which reset as described in Note 13, and have been effectively converted to fixed rate debt using interest rate swaps, as described below.

 

We manage our floating rate debt using interest rate swaps (the “swaps”). As of November 30, 2010, we had two swaps that converted an aggregate notional principal of $125 million from floating interest rate payments under our 7- and 10-year Senior Notes to fixed interest rate payments at 5.89 and 6.01 percent, respectively. In the swap transactions, we maintain two contracts to pay fixed rates of interest on an aggregate notional principal amount of $125 million at rates of 5.04 and 5.11 percent on our 7- and 10-year Senior Notes, respectively, while simultaneously receiving floating rate interest payments set at 0.29 percent as of November 30, 2010 on the same notional amounts. The fixed rate side of the swap will not change over the life of the swap. The floating rate payments are reset quarterly based on three month LIBOR. The resets are concurrent with the interest payments made on the underlying debt. Changes in the spread between the fixed rate payment side of the swap and the floating rate receipt side of the swap fully offset the change in any period of the underlying debt’s floating rate payments. These swaps are used to reduce the Company’s risk of increased interest costs; however, when interest rates drop significantly below the swap rates, we lose the benefit that our floating rate debt would provide, if not managed with swaps. The swaps are considered highly effective.

 

19



 

The following tables summarize the fair values of our various derivative instruments at November 30, 2010 and February 28, 2010:

 

FAIR VALUES OF DERIVATIVE INSTRUMENTS IN THE CONSOLIDATED BALANCE SHEETS

(in thousands)

November 30, 2010

Designated as hedging instruments

 

Hedge Type

 

Final
Settlement
Date

 

Notional
Amount

 

Derivative
Assets,
Current

 

Derivative
Assets,
Noncurrent

 

Accrued
Expenses
and Other
Current
Liabilities

 

Derivative
Liabilities,
Noncurrent

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency contracts - sell Pounds

 

Cash flow

 

2/2012

 

£

10,700

 

$

355

 

$

156

 

$

-

 

$

-

 

Currency contracts - sell Canadian

 

Cash flow

 

12/2011

 

$

8,000

 

80

 

43

 

-

 

-

 

Currency contracts - sell Euros

 

Cash flow

 

2/2012

 

7,000

 

121

 

-

 

-

 

-

 

Subtotal

 

 

 

 

 

 

 

556

 

199

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

Cash flow

 

6/2014

 

$

125,000

 

-

 

-

 

4,222

 

7,621

 

Total fair value

 

 

 

 

 

 

 

$

556

 

$

199

 

$

4,222

 

$

7,621

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

February 28, 2010

Designated as hedging instruments

 

Hedge Type

 

Final
Settlement
Date

 

Notional
Amount

 

Derivative
Assets,
Current

 

Derivative
Assets,
Noncurrent

 

Accrued
Expenses
and Other
Current
Liabilities

 

Derivative
Liabilities,
Noncurrent

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency contracts - sell Pounds

 

Cash flow

 

2/2011

 

£

5,000

 

$

651

 

$

-

 

$

-

 

$

-

 

Currency contracts - sell Canadian

 

Cash flow

 

12/2010

 

$

6,000

 

144

 

-

 

-

 

-

 

Subtotal

 

 

 

 

 

 

 

795

 

-

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

Cash flow

 

6/2014

 

$

125,000

 

-

 

-

 

4,951

 

7,070

 

Total fair value

 

 

 

 

 

 

 

$

795

 

$

-   

 

$

4,951

 

$

7,070

 

 

The pre-tax effect of derivative instruments for the three- and nine-month periods ended November 30, 2010 and 2009 is as follows:

 

PRE TAX EFFECT OF DERIVATIVE INSTRUMENTS

(in thousands)

 

 

Three Months Ended November 30,

 

 

 

Gain \ (Loss)
Recognized in OCI
(effective portion)

 

Gain \ (Loss) Reclassified
from Accumulated Other
Comprehensive Loss into Income

 

Gain \ (Loss) Recognized
as Income (1)

 

 

 

2010

 

2009

 

Location

 

2010

 

2009

 

Location

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency contracts - ordinary and

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

cash flow hedges

 

$

(702)

 

$

(233)

 

SG&A

 

$

(38)

 

$

(312)

 

SG&A

 

$

(41)

 

$

(18)

 

Interest rate swaps - cash flow hedges

 

(187)

 

(2,739)

 

Interest expense

 

(1,490)

 

(1,484)

 

 

 

-     

 

-     

 

Total

 

$

(889)

 

$

(2,972)

 

 

 

$

(1,528)

 

$

(1,796)

 

 

 

$

(41)

 

$

(18)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended November 30,

 

 

 

Gain \ (Loss)
Recognized in OCI
(effective portion)

 

Gain \ (Loss) Reclassified
from Accumulated Other
Comprehensive Loss into Income

 

Gain \ (Loss) Recognized
as Income (1)

 

 

 

2010

 

2009

 

Location

 

2010

 

2009

 

Location

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency contracts - ordinary and

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

cash flow hedges

 

$

72 

 

$

(1,008)

 

SG&A

 

$

112 

 

$

106 

 

SG&A

 

$

(76)

 

$

28 

 

Interest rate swaps - cash flow hedges

 

(4,324)

 

(4,465)

 

Interest expense

 

(4,502)

 

(5,003)

 

 

 

-     

 

-     

 

Total

 

$

(4,252)

 

$

(5,473)

 

 

 

$

(4,390)

 

$

(4,897)

 

 

 

$

(76)

 

$

28 

 

 

(1)  The amounts shown represent the ineffective portion of the change in fair value of a cash flow hedge.

 

20



 

Counterparty credit risk - Financial instruments, including foreign currency contracts and interest rate swaps, expose us to counterparty credit risk for nonperformance. We manage our exposure to counterparty credit risk through only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. Although our theoretical credit risk is the replacement cost at the then estimated fair value of these instruments, we believe that the risk of incurring credit risk losses is remote.

 

Risks inherent in cash, cash equivalents and investment holdings – Our cash, cash equivalents and investments are subject to interest rate risk, credit risk and liquidity risk. Cash consists of both interest bearing and non-interest bearing disbursement or short-term investment accounts. Cash equivalents consist of commercial paper and money market investment accounts. Long-term investments consist of AAA rated ARS. The following table summarizes cash, cash equivalents and long-term investments we held at November 30, 2010 and February 28, 2010:

 

CASH, CASH EQUIVALENTS AND LONG-TERM INVESTMENTS

(in thousands)

 

 

November 30, 2010

 

February 28, 2010

 

 

 

Carrying

 

Range of

 

Carrying

 

Range of

 

 

 

Amount

 

Interest Rates

 

Amount

 

Interest Rates

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

Cash, interest and non-interest-bearing accounts - unrestricted

 

$

44,754

 

0.00 to 1.65%

 

$

6,234

 

0.00 to 2.00%

 

Cash, interest and non-interest-bearing accounts - restricted

 

1,377

 

0.00 to 1.25%

 

1,053

 

0.00 to 2.50%

 

Commercial paper

 

8,640

 

0.13 to 0.16%

 

88,822

 

0.03 to 0.18%

 

Money market accounts

 

15,852

 

0.07 to 3.66%

 

14,099

 

0.01 to 3.98%

 

Total cash and cash equivalents

 

$

70,623

 

 

 

$

110,208

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term investments - auction rate securities

 

$

20,223

 

1.61 to 2.75%

 

$

20,534

 

1.73 to 8.44%

 

 

Our cash balances at November 30, 2010 and February 28, 2010 include restricted cash of $1.38 and $1.05 million, respectively, denominated in Venezuelan Bolivares Fuertes, shown above under the heading “Cash, interest and non-interest-bearing accounts – restricted.” The balances arise from our operations within the Venezuelan market.  The Venezuelan government enforces restrictions on transfers of cash out of the country and controls exchange rates.  We have made formal applications to repatriate this cash at an official exchange rate currently pertinent to us, which is 4.30 Bolivares Fuertes to $1.00; however, the Company has not yet received approval of these applications.  Until we are able to officially repatriate cash from Venezuela, we intend to use these cash balances in-country to continue to fund operations.  We do not otherwise rely on these restricted funds as a source of liquidity.

 

Most of our cash equivalents and investments are in commercial paper, money market accounts and ARS with frequent rate resets; therefore, we believe there is no material interest rate risk. In addition, our commercial paper and ARS are from issuers with high credit ratings; therefore, we believe the commercial paper and ARS do not present a significant credit risk.

 

We hold investments in ARS collateralized by student loans (with underlying maturities from 18 to 35 years). Substantially all of the collateral is guaranteed by the U.S. government under the Federal Family Education Loan Program. Liquidity for these securities was normally dependent on an auction process that reset the applicable interest rate at pre-determined intervals, ranging from 7 to 35 days. Beginning in February 2008, the auctions for the ARS held by us and others were unsuccessful, requiring us to hold them beyond their typical auction reset dates. Auctions fail when there is insufficient demand. However, this does not represent a default by the issuer of the security. Upon an auction’s failure, the interest rates reset based on a formula contained in the security. The securities will continue to accrue interest and be auctioned until one of the following occurs: the auction succeeds; the issuer calls the securities; or the securities mature. ARS are currently classified as non-current assets held for sale under the heading “Other assets” in our consolidated balance sheets.

 

21



 

At November 30, 2010 and February 28, 2009, we had cumulative pre-tax unrealized losses on our ARS of $1.88 and $1.87 million, respectively, which are reflected in accumulated other comprehensive loss in our accompanying consolidated condensed balance sheets, net of related tax effects of $0.64 million.  The recording of these unrealized losses is not a result of the quality of the underlying collateral, but rather a markdown reflecting a lack of liquidity and other market conditions. For the three- and nine-month periods ended November 30, 2010, we liquidated $0.10 and $0.30 million, respectively, of ARS at par. For the three- and nine-month periods ended November 30, 2009, we liquidated $0.05 and $0.15 million, respectively, of ARS at par.

 

Note 16 – Repurchase of Helen of Troy Common Stock

 

Under the latest program approved by our Board of Directors, as of November 30, 2010, we are authorized to purchase up to 1,200,650 shares of common stock in the open market or through private transactions. During the fiscal quarters ended November 30, 2010 and May 31, 2010, we did not repurchase any common stock.  During the fiscal quarter ended August 31, 2010, we repurchased and retired 80,000 shares of common stock at a total purchase price of $1.80 million, for a $22.49 per share average price. During the fiscal quarters ended May 31, 2009 and November 30, 2009, our chief executive officer tendered a combined total of 1,438,109 shares of common stock having a market value of $30.15 million as payment for the exercise price and related federal tax obligations arising from the exercise of options. We accounted for this activity as a purchase and retirement of the shares at an average price of $20.97 per share. During the fiscal quarter ended May 31, 2009, we purchased on the open market and retired 47,648 shares of common stock at a total purchase price of $0.42 million, for an $8.80 per share average price.

 

Note 17 – Share-Based Compensation Plans

 

We have options outstanding under two expired and two active share-based compensation plans. The Company recorded share-based compensation expense in SG&A for the three- and nine-month periods ended November 30, 2010 and 2009, respectively, as follows:

 

SHARE BASED PAYMENT EXPENSE

(in thousands, except per share data)

 

 

Three Months Ended November 30,

 

Nine Months Ended November 30,

 

 

 

2010

 

2009

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

$

402

 

$

433

 

$

1,218

 

$

995

 

Restricted stock grants

 

-    

 

-    

 

258

 

176

 

Employee stock purchase plan

 

-    

 

-    

 

71

 

93

 

Share-based payment expense

 

402

 

433

 

1,547

 

1,264

 

Less income tax benefits

 

(25

)

(27

)

(75

)

(62

)

Share-based payment expense, net of income tax benefits

 

$

377

 

$

406

 

$

1,472

 

$

1,202

 

 

 

 

 

 

 

 

 

 

 

Earnings per share impact of share based payment expense:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.01

 

$

0.01

 

$

0.05

 

$

0.04

 

Diluted

 

$

0.01

 

$

0.01

 

$

0.05

 

$

0.04

 

 

22


 


 

A summary of option activity as of November 30, 2010, and changes during the nine months then ended is as follows:

 

SUMMARY OF STOCK OPTION ACTIVITY

(in thousands, except contractual term and per share data)

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

Exercise

 

Grant Date

 

Remaining

 

Aggregate

 

 

 

 

 

Price

 

Fair Value

 

Contract Term

 

Intrinsic

 

 

 

Options

 

(per share)

 

(per share)

 

(in years)

 

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at February 28, 2010

 

2,899

 

$

18.13

 

$

6.57

 

4.06

 

$

18,742

 

Granted

 

7

 

23.70

 

 

 

 

 

 

 

Exercised

 

(141

)

(20.28

)

 

 

 

 

855

 

Forfeited / expired

 

(50

)

(21.53

)

 

 

 

 

 

 

Outstanding at November 30, 2010

 

2,715

 

$

17.97

 

$

6.52

 

3.33

 

$

16,727

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at November 30, 2010

 

2,198

 

$

17.15

 

$

6.08

 

2.64

 

$

15,376

 

 

Note 18 – Subsequent Events Kaz Inc. Acquisition and Related Debt Financing

 

Kaz, Inc. Acquisition – On December 31, 2010, we acquired, through a wholly-owned subsidiary of the Company, 100% of the outstanding capital stock of Kaz, a provider of a broad range of consumer products in two primary product categories consisting of healthcare and home environment. Significant products of Kaz include humidifiers, de-humidifiers, vaporizers, thermometers, air purifiers, fans, portable heaters, heating pads and electronic mosquito traps.  Kaz sources, markets and distributes a number of well-recognized brands including:  Healthcare: Vicks®, Braun®, Kaz®, Smart-Temp®, and SoftHeat®; and Home Environment: Honeywell®, Duracraft®, Dunlap®, Stinger® and Nosquito®.  Its products are sold primarily through mass merchandisers, drugstore chains, warehouse clubs, catalogs, grocery stores, specialty stores, home improvement stores and medical distributors in the United States, Europe, Latin America and the Asia-Pacific region. Kaz maintains its headquarters in Southborough, Massachusetts.

 

The following table summarizes the sources and consideration paid for Kaz, subject to certain future adjustments, including an adjustment for estimated closing date working capital.

 

KAZ, INC - SOURCES OF CONSIDERATION PAID AT DECEMBER 31, 2010

(in thousands)

 

 

 

 

Cash

 

$

72,037

 

Advances under the 2010 RCA

 

94,000

 

Loans under the TLCA

 

100,000

 

Total consideration paid

 

$

266,037

 

 

The acquisition will help broaden the Company’s geographic footprint, increase our mutual significance with common customers and vendors, and expand our customer base worldwide.

 

Because of the proximity of the acquisition closing date to the date of filing this report, the Company has not completed Kaz’s accounting through the date of acquisition, or the initial accounting for the acquisition, including determining the acquisition-date fair values of the identifiable acquired assets and liabilities assumed.   Management will use third party valuations and other detailed analysis to complete our analysis of the economic lives of assets acquired, make fair value estimates and allocate the purchase price.  Depending on the results of this analysis, we will likely, in future periods, record amortization expense on the finite lived intangible assets associated with the acquisition.

 

23



 

Also, without the initial accounting for the acquisition, it was impractical to provide complete and suitably adjusted supplemental pro forma financial disclosures showing the impact of the transaction on historical net sales revenue and net income.

 

We expect to complete the analysis required to record the initial accounting for the acquisition and present the pro forma impact of Kaz on historical consolidated net sales revenue and net income during the fourth quarter of fiscal 2011.

 

Acquisition-related costs incurred through November 30, 2010 were approximately $1.0 million. Acquisition-related costs incurred through December 31, 2010 were approximately $1.50 million.  All Kaz acquisition-related costs have been or will be recognized in SG&A during the period in which they are incurred.

 

New Revolving Line of Credit Agreement and Term Loan Credit Agreement – On December 31, 2010, we terminated the 2004 RCA and in connection with our acquisition of Kaz, after having entered into a new Revolving Line of Credit Agreement (the “2010 RCA”) with Bank of America, N.A. on December 30, 2010. The 2010 RCA provides for an unsecured revolving commitment of up to $150 million, subject to the terms and limitations described below.  The commitment under the 2010 RCA terminates on December 30, 2015.  On December 31, 2010, we also entered into a $100 million unsecured Term Loan Credit Agreement (the “TLCA”) with Bank of America, N.A., which matures on March 30, 2011.  We intend to repay in full and terminate the TLCA, replacing it with permanent long-term financing prior to the maturity date of the TLCA.

 

Borrowings under the 2010 RCA accrue interest at a “Base Rate” plus a margin of 0.25 to 1.375 percent per annum based on the Leverage Ratio (as defined in the 2010 RCA) at the time of borrowing.  The base rate is equal to the highest of the Federal Funds Rate (as defined in the 2010 RCA) plus 0.50 percent, Bank of America’s prime rate, or the one month LIBOR rate plus 1 percent.  Alternatively, if we elect, borrowings accrue interest based on the respective 1, 2, 3, or 6-month LIBOR rate plus a margin of 1.25 to 2.375 percent per annum based upon the Leverage Ratio at the time of the borrowing. We incur loan commitment fees at a rate ranging from 0.30 to 0.50 percent per annum on the unused balance of the 2010 RCA.  We incur letter of credit fees under the 2010 RCA at a rate ranging from 1.25 to 2.375 percent per annum on the face value of any letter of credit. The TLCA accrues interest at the “Base Rate” plus a margin of 2.00 percent per annum, or alternatively, if we elect, at the one month LIBOR rate plus a margin of 3.00 percent per annum. Outstanding letters of credit reduce the borrowing availability under the 2010 RCA on a dollar for dollar basis. The 2010 RCA, the TLCA and our other debt are unconditionally guaranteed, on a joint and several basis, by the parent company, Helen of Troy Limited and/or certain subsidiaries.

 

The 2010 RCA, the TLCA and our other debt agreements require the maintenance of maximum debt leverage and interest coverage ratios, specify minimum consolidated net worth levels and contain other customary covenants, which restrict us, among other things, from incurring liens on any of our properties, except under certain conditions, and limit our ability to pay dividends and repurchase shares of our common stock.  As of December 31, 2010, all our debt agreements effectively limited our ability to incur more than an estimated $147.44 million of additional debt from all sources, including draws on the 2010 RCA.  We are currently in compliance with the terms of the 2010 RCA, the TLCA and our other debt agreements.

 

In connection with the 2010 RCA and TLCA, the Company has incurred $2.05 million in new debt acquisition costs through December 31, 2010 that will be amortized over the terms of the associated agreements.

 

24



 

ITEM 2.     MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

This discussion contains a number of forward-looking statements, all of which are based on current expectations. Actual results may differ materially due to a number of factors, including those discussed in Part I, Item 3. “Quantitative and Qualitative Disclosures about Market Risk”, “Information Regarding Forward Looking Statements”, and “Risk Factors” in the Company’s most recent annual report on Form 10-K and its other filings with the Securities and Exchange Commission (the “SEC”).  This discussion should be read in conjunction with our consolidated condensed financial statements included under Part I, Item 1 of this report.

 

OVERVIEW OF THREE- AND NINE-MONTHS ENDED NOVEMBER 30, 2010 RESULTS:

 

On a historical basis, our third fiscal quarter’s net sales revenue volume is generally the highest of each fiscal year. Over the last three completed fiscal years, our third fiscal quarter’s net sales have averaged approximately 30 percent of the year’s total sales. Overall, we believe that increased retail sales during the quarter and the rise in domestic consumer confidence are positive indicators for a growth in consumer spending in the fourth fiscal quarter. However, our sales continue to be negatively impacted by certain trends in consumer spending, including the consumers’ focus on moderate and value-priced merchandise. Therefore, we continue to remain cautious regarding our outlook as the economy continues a slow recovery that began earlier this fiscal year and expect a modest growth in consumer demand during calendar 2011.

 

Consolidated net sales revenue for the three- and nine-month periods ended November 30, 2010 increased 8.2 and 9.0 percent to $205.00 and $539.98 million, respectively, compared to $189.40 and $495.47 million, respectively, for the same periods last year.  Net sales revenue in our Personal Care segment was up 9.2 and 8.9 percent, respectively for the three- and nine-month periods ended November 30, 2010, when compared to the same periods last year.  Growth in the segment was primarily due to our acquisition of the Pert Plus and Sure business, which provided three and eight months of additional net sales revenue, respectively, for the three- and nine-month periods ended November 30, 2010.  In addition, the nine month period ended November 30, 2010 includes an extra month of net sales revenue from the Infusium acquisition when compared with the same period last year (which only included eight months of revenue due to Infusium being acquired on March 31, 2009).  Sales of appliances and accessories declined when compared to the same periods last year, which we believe is in line with overall industry performance for the category.  A significant portion of these declines came from our international operations and are due to weak economic conditions and unfavorable foreign currency fluctuations.  We continue to expect that sales revenue performance in our Personal Care segment’s product lines will be heavily dependent on improvements in domestic and international employment, housing markets and consumers’ personal finances.   Net sales revenue in our Housewares segment was up 6.0 and 9.2 percent, respectively, for the three- and nine-month periods ended November 30, 2010, when compared to the same periods last year.  The growth rate in the Housewares segment was slower compared to recent quarters due to the continued maturation of its domestic markets and certain delays in new product introductions.  While we believe in the segment’s organic growth potential, we remain cautious about its ability to sustain the pace of net sales revenue growth that it has historically experienced. We expect future net sales revenue quarterly growth rates for the segment to stabilize around mid to high single digits.

 

From a geographic perspective, domestic (U.S. and Canada) net sales revenue growth for the three- and nine- month periods ended November 30, 2010 was offset by net sales revenue declines in our international operations, whose businesses are struggling under weaker local economies and the impacts of unfavorable currency fluctuations.  Domestic (U.S. and Canada) net sales revenues for the three- and nine-month periods ended November 30, 2010 contributed 10.0 and 10.1 percent to net sales revenue growth, when compared to the same periods last year.  International operations net sales revenue declines for the three- and nine-month periods ended November 30, 2010, partially offset domestic net sales revenue growth with declines of 1.8 and 1.1 percentage points, respectively, when compared to the same periods last year.

 

25



 

In addition to our net sales revenue performance discussed above, highlights of the three- and nine-month periods ended November 30, 2010 include the following:

 

·                  Consolidated gross profit margin as a percentage of net sales revenue for the fiscal quarter ended November 30, 2010 increased 1.1 percentage points to 45.2 percent compared to 44.1 percent for the same period last year.  Consolidated gross profit margin as a percentage of net sales for the nine month period ended November 30, 2010 increased 2.9 percentage points to 45.5 percent compared to 42.6 percent for the same period last year.

 

·                  Selling, general and administrative expense (“SG&A”) as a percentage of net sales revenue increased 1.6 percentage points to 29.9 percent for the three months ended November 30, 2010, compared to 28.3 percent for the same period last year.  SG&A expense as a percentage of net sales revenue for the nine months ended November 30, 2010 increased 1.7 percentage points to 30.2 percent compared to 28.5 percent for the same period last year.   The increases in SG&A as a percentage of net sales revenue are primarily due to the impact of higher advertising expenses incurred to support our new Pert Plus, Sure and Infusium product lines.

 

·                  For the three- and nine-month periods ended November 30, 2010, operating income before impairment was $31.54 and $82.43 million, respectively, compared to $29.86 and $69.70 million, respectively, for the same periods last year, which represents a year-over-year improvement of 5.6 and 18.3 percent, respectively.

 

·                  For the three- and nine-month periods ended November 30, 2010, our net income was $27.06 and $68.92 million, respectively, compared to $24.73 and $55.15 million, respectively, for the same periods last year.  For the three- and nine-month periods ended November 30, 2010, our diluted earnings per share was $0.86 and $2.20 compared to $0.80 and $1.79, respectively, for the same periods last year.

 

RECENT ACQUISTIONS:

 

On December 31, 2010, we acquired, through a wholly-owned subsidiary of the Company, 100% of the outstanding capital stock of Kaz, Inc. (“Kaz”), a provider of a broad range of consumer products in two primary product categories consisting of healthcare and home environment.  Significant products of Kaz include humidifiers, de-humidifiers, vaporizers, thermometers, air purifiers, fans, portable heaters, heating pads and electronic mosquito traps.  Kaz sources, markets and distributes a number of well-recognized brands including:  Healthcare: Vicks®, Braun®, Kaz®, Smart-Temp®, and SoftHeat®; and Home Environment: Honeywell®, Duracraft®, Dunlap®, Stinger® and Nosquito®. Its products are sold primarily through mass merchandisers, drugstore chains, warehouse clubs, catalogs, grocery stores, specialty stores, home improvement stores and medical distributors in the United States, Europe, Latin America and the Asia-Pacific region. Kaz maintains its headquarters in Southborough, Massachusetts.

 

We paid $266.04 million for the capital stock of Kaz, which is subject to certain future adjustments, including an adjustment for actual verses estimated closing date working capital.  The acquisition was paid for with $72.04 million of cash and $194.00 million of new debt as further described under “2010 Revolving Line of Credit Agreement and Other Debt Agreements” beginning on page 37.

 

The acquisition will help broaden the Company’s geographic footprint, increase our significance with common customers and vendors, and expand our customer base worldwide.   Kaz’s unaudited net sales revenue for the twelve months ended October 31, 2010, the end of its most recently completed fiscal quarter was $419.38 million.  We expect the acquisition of Kaz to be accretive to earnings for the fiscal year ended February 29, 2012.  Kaz operates on lower gross profit and operating margins than those of our consolidated businesses existing before the

 

26



 

acquisition.  Accordingly, we expect that our overall consolidated rates for these metrics will be diluted by the acquisition.

 

On March 31, 2010, we completed the acquisition of certain assets and liabilities of the Pert Plus hair care and Sure antiperspirant and deodorant businesses from Innovative Brands, LLC for a net cash purchase price of $69.00 million, which we paid with cash on hand.  In the second fiscal quarter, we substantially completed the integration of this acquisition into our operations.  The acquisition is a significant addition to the Company’s grooming, skin care and hair care solutions product portfolio, but has required minimal additional staffing and infrastructure. We market Pert Plus and Sure products primarily into mass retail and drug channels.  Net sales revenue for the three- and nine-months ended November 30, 2010 includes three and eight months, respectively of Pert Plus and Sure activity totaling $17.59 and $48.42 million in net sales, respectively.

 

27


 


 

RESULTS OF OPERATIONS

 

Comparison of three- and nine-month periods ended November 30, 2010 to the same periods ended November 30, 2009

 

The following table sets forth, for the periods indicated, our selected operating data, in U.S. Dollars, as a year-over-year percentage change, and as a percentage of net sales revenue.

 

SELECTED OPERATING DATA

(dollars in thousands)

 

 

 

Quarter Ended November 30,

 

 

 

 

 

 

 

% of Sales Revenue, net

 

 

 

2010

 

2009

 

 

$ Change

 

% Change

 

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales revenue, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Personal Care Segment

 

 

$

146,506

 

$

134,206

 

 

$

12,300

 

9.2%

 

 

71.5

%

70.9%  

Housewares Segment

 

 

58,495

 

55,193

 

 

3,302

 

6.0%

 

 

28.5

%

29.1%  

Total sales revenue, net

 

 

205,001

 

189,399

 

 

15,602

 

8.2%

 

 

100.0

%

100.0%  

Cost of goods sold

 

 

112,256

 

105,877

 

 

6,379

 

6.0%

 

 

54.8

%

55.9%  

Gross profit

 

 

92,745

 

83,522

 

 

9,223

 

11.0%

 

 

45.2

%

44.1%  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general, and administrative expense

 

 

61,205

 

53,658

 

 

7,547

 

14.1%

 

 

29.9

%

28.3%  

Operating income before impairment

 

 

31,540

 

29,864

 

 

1,676

 

5.6%

 

 

15.4

%

15.8%  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset impairment charges

 

 

-    

 

-    

 

 

-    

 

0.0%

 

 

0.0

%

0.0%  

Operating income

 

 

31,540

 

29,864

 

 

1,676

 

5.6%

 

 

15.4

%

15.8%  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nonoperating income (expense), net

 

 

156

 

125

 

 

31

 

24.8%

 

 

0.1

%

0.1%  

Interest expense

 

 

(2,081

)

(2,146

)

 

65

 

-3.0%

 

 

-1.0

%

-1.1%  

Total other income (expense)

 

 

(1,925

)

(2,021

)

 

96

 

-4.8%

 

 

-0.9

%

-1.1%  

Income before income taxes

 

 

29,615

 

27,843

 

 

1,772

 

6.4%

 

 

14.4

%

14.7%  

Income tax expense

 

 

2,552

 

3,110

 

 

(558

)

-17.9%

 

 

1.2

%

1.6%  

Net income

 

 

$

27,063

 

$

24,733

 

 

$

2,330

 

9.4%

 

 

13.2

%

13.1%  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended November 30,

 

 

 

 

 

 

% of Sales Revenue, net

 

 

 

2010

 

2009

 

 

$ Change

 

% Change

 

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales revenue, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Personal Care Segment

 

 

$

377,853

 

$

347,018

 

 

$

30,835

 

8.9%

 

 

70.0

%

70.0%  

Housewares Segment

 

 

162,124

 

148,447

 

 

13,677

 

9.2%

 

 

30.0

%

30.0%  

Total sales revenue, net

 

 

539,977

 

495,465

 

 

44,512

 

9.0%

 

 

100.0

%

100.0%  

Cost of goods sold

 

 

294,529

 

284,540

 

 

9,989

 

3.5%

 

 

54.5

%

57.4%  

Gross profit

 

 

245,448

 

210,925

 

 

34,523

 

16.4%

 

 

45.5

%

42.6%  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general, and administrative expense

 

 

163,020

 

141,230

 

 

21,790

 

15.4%

 

 

30.2

%

28.5%  

Operating income before impairment

 

 

82,428

 

69,695

 

 

12,733

 

18.3%

 

 

15.3

%

14.1%  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset impairment charges

 

 

501

 

900

 

 

(399

)

-44.3%

 

 

0.1

%

0.2%  

Operating income

 

 

81,927

 

68,795

 

 

13,132

 

19.1%

 

 

15.2

%

13.9%  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nonoperating income (expense), net

 

 

490

 

927

 

 

(437

)

-47.1%

 

 

0.1

%

0.2%  

Interest expense

 

 

(6,377

)

(8,192

)

 

1,815

 

-22.2%

 

 

-1.2

%

-1.7%  

Total other income (expense)

 

 

(5,887

)

(7,265

)

 

1,378

 

-19.0%

 

 

-1.1

%

-1.5%  

Income before income taxes

 

 

76,040

 

61,530

 

 

14,510

 

23.6%

 

 

14.1

%

12.4%  

Income tax expense

 

 

7,117

 

6,377

 

 

740

 

11.6%

 

 

1.3

%

1.3%  

Net income

 

 

$

68,923

 

$

55,153

 

 

$

13,770

 

25.0%

 

 

12.8

%

11.1%  

 

28



 

Consolidated net sales revenue:

 

Consolidated net sales revenue for the three- and nine-month periods ended November 30, 2010 increased 8.2 and 9.0 percent to $205.00 and $539.98 million, respectively, compared to $189.40 and $495.47 million, respectively, for the same periods last year.  Net sales revenue in our Personal Care segment was up 9.2 and 8.9 percent, respectively, for the three- and nine-month periods ended November 30, 2010, when compared to the same periods last year.  Net sales revenue in our Housewares segment was up 6.0 and 9.2, respectively, for the three- and nine-month periods ended November 30, 2010, when compared to the same periods last year.  The growth rate in the Housewares segment was slower compared to recent quarters due to the continued maturation of its domestic markets and certain delays in new product introductions.  While we believe in the segment’s organic growth potential, we remain cautious about its ability to sustain the pace of net sales revenue growth that it has historically experienced.

 

Impact of acquisitions on net sales revenue:

 

Net sales revenue from acquisitions contributed 9.3 and 10.2 percentage points, respectively, to our net sales revenue growth for the three- and nine-month periods ended November 30, 2010.  Net sales revenue from acquisitions for the nine month period ended November 30, 2010 included one month of net sales revenue totaling $2.37 million from our Infusium line of shampoos, conditioners and leave-in hair treatments acquired on March 31, 2009. Net sales revenue from acquisitions for three- and nine-month periods ended November 30, 2010, also included three and eight months revenue totaling $17.59 and $48.42 million, respectively, for our Pert Plus hair care and Sure antiperspirant and deodorant product lines acquired on March 31, 2010.  Our core business (business owned and operated over the same fiscal periods last year) had total dollar net sales revenue declines of $1.99 and $6.28 million, respectively, for the three- and nine-month periods ended November 30, 2010, when compared to the same periods last year.  This equates to a 1.1 and 1.3 percentage point decline in net sales revenue, for the three- and nine-month periods ended November 30, 2010, when compared to the same periods last year.  Core business net sales revenue declines for both periods were caused by weak economic conditions in certain key foreign markets and unfavorable foreign currency fluctuations, which reduced U.S. reported net sales revenue by $2.49 million and $3.46 million, respectively. Domestic (U.S. and Canada) core business net sales revenue grew slightly for the three month period ended November 30, 2010, and was essentially flat for the nine month period ended November 30, 2010, when compared to the same periods last year.  Net sales revenue growth in our Housewares segment’s core business was offset by declines in our Personal Care segment’s core business.  The following tables set forth the impact acquisitions had on our net sales revenue:

 

IMPACT OF ACQUISITION ON NET SALES REVENUE

(in thousands)

 

 

Quarter Ended November 30,

 

 

 

2010

 

2009

 

 

 

 

 

 

Prior year’s sales revenue, net

 

 

$

189,399

 

$

 185,619  

 

 

 

 

 

 

Components of net sales revenue change

 

 

 

 

 

Core business

 

 

(1,991

)

(6,053) 

Acquisitions (non-core business net sales revenue)

 

 

17,593

 

9,833  

Change in sales revenue, net

 

 

15,602

 

3,780  

Sales revenue, net

 

 

$

205,001

 

$

189,399  

 

 

 

 

 

 

Total net sales revenue growth

 

 

8.2%

 

2.0% 

Core business

 

 

-1.1%

 

-3.3% 

Acquisitions

 

 

9.3%

 

5.3% 

 

29



 

IMPACT OF ACQUISITION ON NET SALES REVENUE

(in thousands)

 

 

Nine Months Ended November 30,

 

 

 

2010

 

2009

 

 

 

 

 

 

Prior year’s sales revenue, net

 

 

$

495,465

 

$

 484,165  

 

 

 

 

 

 

Components of net sales revenue change

 

 

 

 

 

Core business

 

 

(6,275

)

(19,122) 

Acquisitions (non-core business net sales revenue)

 

 

50,787

 

30,422  

Change in sales revenue, net

 

 

44,512

 

11,300  

Sales revenue, net

 

 

$

539,977

 

$

 495,465  

 

 

 

 

 

 

Total net sales revenue growth

 

 

9.0%

 

2.3% 

Core business

 

 

-1.3%

 

-4.0% 

Acquisitions

 

 

10.3%

 

6.3% 

 

Impact of foreign currencies on net sales revenue:

 

During the three- and nine-month periods ended November 30, 2010, we transacted approximately 16 and 13 percent, respectively, of our net sales revenues in foreign currencies.   During the three- and nine-month periods ended November 30, 2009, we transacted approximately 16 and 15 percent, respectively, of our net sales revenues in foreign currencies.  These transactions were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars, Chilean Pesos, Peruvian Soles, and Venezuelan Bolivares Fuertes.  For the three- and nine-month periods ended November 30, 2010, the impact of net foreign currency exchange rates decreased our international net sales revenue by approximately $2.49 and $3.46 million.  The impact of these fluctuations primarily affected the Personal Care segment’s appliance category.

 

Segment net sales revenue:

 

We operate our business under two segments: Personal Care and Housewares.  Our Personal Care segment’s products include hair dryers, straighteners, curling irons, hairsetters, shavers, mirrors, hot air brushes, home hair clippers and trimmers, paraffin baths, massage cushions, footbaths, body massagers, brushes, combs, hair accessories, liquid and aerosol hair styling products, men’s fragrances, men’s and women’s antiperspirants and deodorants, liquid and bar soaps, shampoos, hair treatments, foot powder, body powder and skin care products.  Our Housewares segment reports the operations of the OXO family of brands whose products include kitchen tools, cutlery, bar and wine accessories, household cleaning tools, food storage containers, tea kettles, trash cans, storage and organization products, hand tools, gardening tools, kitchen mitts and trivets, barbeque tools, rechargeable lighting products and baby-toddler products.  The following table sets forth, for the periods indicated, our net sales revenue and the impact of volume and price mix changes for each segment:

 

SALES REVENUE, NET BY SEGMENT

(dollars in thousands)

 

 

Quarter Ended November 30,

 

$ Change

 

% Change

 

 

 

2010

 

2009

 

 

Volume

 

Price

 

Net

 

Volume

 

Price

 

Net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales revenue, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Personal Care

 

 

$

146,506

 

$

134,206

 

 

 $

8,748

 

$

3,552

 

$

12,300 

 

6.5

%

2.6

%

9.2%  

Housewares

 

 

58,495

 

55,193

 

 

1,786

 

1,516

 

3,302 

 

3.2

%

2.7

%

6.0%  

Total sales revenue, net

 

 

$

205,001

 

$

189,399

 

 

 $

10,534

 

$

5,068

 

$

15,602 

 

5.6

%

2.7

%

8.2%  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended November 30,

 

$ Change

 

% Change

 

 

 

2010

 

2009

 

 

Volume

 

Price

 

Net

 

Volume

 

Price

 

Net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales revenue, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Personal Care

 

 

$

377,853

 

$

347,018

 

 

 $

32,475

 

$

(1,640

)

$

30,835 

 

9.4

%

-0.5

%

8.9%  

Housewares

 

 

162,124

 

148,447

 

 

12,951

 

726

 

13,677 

 

8.7

%

0.5

%

9.2%  

Total sales revenue, net

 

 

$

539,977

 

$

495,465

 

 

 $

45,426

 

$

(914

)

$

44,512 

 

9.2

%

-0.2

%

9.0%  

 

30



 

Personal Care Segment Segment net sales revenue for the three months ended November 30, 2010 increased $12.30 million, or 9.2 percent, to $146.51 million compared with $134.21 million for the same period last year.  Segment net sales revenue for the nine months ended November 30, 2010 increased $30.83 million, or 8.9 percent, to $377.85 million compared with $347.02 million for the same period last year. Net sales revenue increases were attributed primarily to the grooming, skin care and hair care solutions category, which sell at lower per unit prices than appliances overall.  Year-over-year growth in the third quarter was due primarily to an additional three months of net sales revenue from our recent acquisition of the Pert Plus and Sure business, acquired on March 31, 2010.  Sales of appliances and accessories declined when compared to the same period last year, which we believe is in line with overall industry performance for the category.  A significant portion of the decline was due to the impact of weak economic conditions and unfavorable foreign currency fluctuations on our international operations.  Hair care appliance net sales revenue continues to be negatively impacted by cautious consumer spending, which includes an overall shift by consumers to spending on lower price-point personal care items.  We continue to expect that net sales revenue performance in our Personal Care segment will be heavily dependent on improvements in domestic and international employment, housing markets and consumers’ personal finances.

 

Housewares Segment Segment net sales revenue for the three months ended November 30, 2010 increased $3.30 million, or 6.0 percent, to $58.50 million compared with $55.19 million for the same period last year.  Segment net sales revenue for the nine months ended November 30, 2010 increased $13.68 million, or 9.2 percent, to $162.12 million compared with $148.45 million for the same period last year. While our Housewares segment has modestly expanded its distribution, new product introductions across the segment’s existing retail base continues to be the primary driver of growth.  Additional new product introductions, namely our OXO tot infant and toddler feeding, cleaning and bathing products and our OXO Good Grips line of interlocking deep drawer plastic storage bins, began to ship to a limited number of customers during the third fiscal quarter of 2011.

 

While the Housewares segment’s performance continues to demonstrate resistance to recessionary trends, sales revenue growth for the segment is highly dependent on new product innovation, continued product line expansion, new sources of distribution, and geographic expansion.  For the quarter ended November 30, 2010, the growth rate in the Housewares segment was slower compared to recent quarters.  This was due to the segment’s continued maturation of its domestic markets and certain delays in new product introductions.  The delays in new product introductions were due to development capacity constraints, which is attributed, in part, to the impact of the segment’s growth in sourcing needs and underlying manufacturing complexity. During the latest quarter, management reviewed its operations and advanced several initiatives, which will realign and expand its product development team.  We expect these changes will eliminate recent development capacity constraints and improve the time-to-market over the next few fiscal quarters.

 

OXO continues to expand its new product development pipeline and focus on building strong product line assortments.  While we believe in the segment’s organic growth potential, we remain cautious about its ability to sustain the pace of net sales revenue growth that it has historically experienced.

 

31



 

Consolidated gross profit margin:

 

Consolidated gross profit margin as a percentage of net sales revenue for the fiscal quarter ended November 30, 2010 increased 1.1 percentage points to 45.2 percent compared to 44.1 percent for the same period last year. Consolidated gross profit margin as a percentage of net sales revenue for the nine month period ended November 30, 2010 increased 2.9 percentage points to 45.5 percent compared to 42.6 percent for the same period last year.

 

Gross profit margin improvements for the three- and nine-month periods ended November 30, 2010 were primarily the result of:

 

·     the impact of commodity price decreases in fiscal 2010 that continue to cycle through cost of goods sold; and

 

·    a change in sales mix as grooming, skin care and hair care solutions products with comparatively higher margins became a more significant portion of the Company’s overall net sales revenue, particularly as a result of our more recent brand acquisitions.

 

The gross profit margin improvements were partially offset by increases in inbound freight costs.

 

Our product sourcing mix is heavily dependent on imports from China.  There is a possibility that China will move its currency off a peg to the U.S. dollar, which will likely increase our product costs over time.  In addition, there has been upward pressure on raw material, labor and inbound transportation costs.  Accordingly, we remain cautious about the expectation of sustained gross profit margin improvement throughout the remainder of fiscal 2011 and into the first half of fiscal year 2012.

 

Selling, general and administrative expense:

 

In order to provide a better understanding of the impact that certain specified items had on our operations, the analysis that follows reports SG&A excluding the items described in the table below.  This financial measure is non-GAAP financial information as contemplated by SEC Regulation G, Rule 100, and the accompanying table reconciles this measure to the corresponding GAAP-based measure presented in our consolidated condensed statements of income.

 

IMPACT OF SPECIFIED ITEMS ON SELLING, GENERAL AND ADMINISTRATIVE EXPENSE

(dollars in thousands)

 

 

Quarter Ended November 30,

 

 

 

 

 

% of Sales Revenue, net

 

 

2010

 

2009

 

 

$ Change

 

% Change

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SG&A, as reported

 

$

61,205

 

$

53,658

 

 

$

7,547

 

14.1%

 

29.9%

 

28.3%

Advertising

 

(13,164

)

(7,709

)

 

(5,455

)

70.8%

 

-6.4%

 

-4.1%

Foreign exchange gains

 

400

 

138

 

 

262

 

*    

 

0.2%

 

0.1%

Insurance claim gains (loss)

 

31

 

(33

)

 

64

 

*    

 

0.0%

 

0.0%

SG&A, without specified items

 

$

48,472

 

$

46,054

 

 

$

2,418

 

5.3%

 

23.6%

 

24.3% 

 

 

 

Nine Months Ended November 30,

 

 

 

 

 

% of Sales Revenue, net

 

 

2010

 

2009

 

 

$ Change

 

% Change

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SG&A, as reported

 

$

163,020

 

$

141,230

 

 

$

21,790

 

15.4%

 

30.2%

 

28.5%

Advertising

 

(27,507

)

(15,998

)

 

(11,509

)

71.9%

 

-5.1%

 

-3.2%

Foreign exchange gains

 

491

 

3,432

 

 

(2,941

)

*    

 

0.1%

 

0.7%

Insurance claim gains

 

387

 

510

 

 

(123

)

-24.1%

 

0.1%

 

0.1%

SG&A, without specified items

 

$

136,391

 

$

129,174

 

 

$

7,217

 

5.6%

 

25.3%

 

26.1% 

 

*    Calculation is not meaningful

 

32



 

The Company believes that this non-GAAP measure provides useful information to management and investors regarding financial and business trends relating to its financial condition and results of operations.  The Company believes that this non-GAAP measure, in combination with the Company’s financial results calculated in accordance with GAAP, provides investors with additional perspective regarding the impact of specified items on SG&A.  The Company further believes that the specified items excluded from SG&A do not accurately reflect the underlying performance of its continuing operations for the period in which they are incurred, even though some of these excluded items may be incurred and reflected in the Company’s GAAP financial results in the foreseeable future.  The material limitation associated with the use of non-GAAP financial measures is that non-GAAP measures do not reflect the full economic impact of the Company’s activities.  The Company’s non-GAAP measure is not prepared in accordance with GAAP, is not an alternative to GAAP financial information and may be calculated differently than non-GAAP financial information disclosed by other companies.  Accordingly, undue reliance should not be placed on non-GAAP information.

 

For the fiscal quarter ended November 30, 2010, SG&A reported in our consolidated condensed statements of income as a percentage of net sales revenue increased 1.6 percentage points to 29.9 percent compared to 28.3 percent for the same period last year.  For the nine month period ended November 30, 2010, SG&A reported in our consolidated condensed statements of income as a percentage of net sales revenue increased 1.7 percentage points to 30.2 percent compared to 28.5 percent for the same period last year.

 

SG&A for the three- and nine-months ended November 30, 2010 includes advertising expense of $13.16 and $27.51 million, respectively, net foreign exchange gains of $0.40 and $0.49 million, respectively, and insurance claim gains of $0.03 and $0.39 million, respectively.  Together, these items resulted in a net expense impact on SG&A for the three- and nine-months ended November 30, 2010 of $12.73 and $26.63 million, respectively. SG&A for the three- and nine-months ended November 30, 2009 included advertising expense of $7.71 and $16.00 million, respectively, net foreign exchange gains of $0.14 and $3.43 million, respectively, and insurance claim gains (losses) of ($0.03) and $0.51 million, respectively.  Together, these items resulted in a net expense impact to SG&A for the three- and nine-months ended November 30, 2009 of $7.60 and $12.06 million, respectively.   The preceding table shows the impact of excluding these specified items from both periods.  Excluding the impact of the specified items shown in the previous table from the fiscal quarters presented, SG&A as a percentage of net sales revenue decreased 0.7 percentage points to 23.6 percent for the three months ended November 30, 2010 compared to 24.3 percent for the same period last year.  Excluding the impact of the specified items shown in the previous table from the nine months presented, SG&A as a percentage of net sales decreased 0.8 percentage points to 25.3 percent for the nine months ended November 30, 2010 compared to 26.1 percent for the same period last year.

 

For the third quarter of fiscal 2011, advertising expense exceeded last year’s third fiscal quarter advertising expense by approximately $5.46 million.  The increase in advertising expense for the three month period ended November 30, 2010 is due to the launch of new Personal Care media advertising campaigns for Pert Plus, Sure and Infusium products.  We plan to continue providing advertising support to these brands with expenditures expected to be incurred more evenly over the four quarters in the next fiscal year.

 

33



 

Operating income before impairment by segment:

 

The following table sets forth, for the periods indicated, our operating income before impairment charges by segment, as a year-over-year percentage change and as a percentage of net sales revenue for each segment and the Company overall:

 

OPERATING INCOME BEFORE IMPAIRMENT, BY SEGMENT

(dollars in thousands)

 

 

Quarter Ended November 30,

 

 

 

 

 

% of Sales Revenue, net

 

 

2010

 

2009

 

 

$ Change

 

% Change

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Personal Care

 

$

18,816

 

$

16,591

 

 

$

2,225

 

13.4%

 

12.8%

 

12.4%

Housewares

 

12,724

 

13,273

 

 

(549

)

-4.1%

 

21.8%

 

24.0%

Total operating income before impairment

 

$

31,540

 

$

29,864

 

 

$

1,676

 

5.6%

 

15.4%

 

15.8%

 

 

 

Nine Months Ended November 30,

 

 

 

 

 

% of Sales Revenue, net

 

 

2010

 

2009

 

 

$ Change

 

% Change

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Personal Care

 

$

47,142

 

$

36,503

 

 

$

10,639

 

29.1%

 

12.5%

 

10.5%

Housewares

 

35,286

 

33,192

 

 

2,094

 

6.3%

 

21.8%

 

22.4%

Total operating income before impairment

 

$

82,428

 

$

69,695

 

 

$

12,733

 

18.3%

 

15.3%

 

14.1%

 

The Personal Care segment’s operating income before impairment charges increased $2.23 million, or 13.4 percent, for the fiscal quarter ended November 30, 2010, when compared to the same period last year.  The segment’s operating income before impairment charges increased $10.64 million, or 29.1 percent, for the nine months ended November 30, 2010, when compared to the same period last year. These improvements were due to an overall improvement in gross margin combined with the favorable impact of the Pert Plus, Sure and Infusium acquisitions on the sales and profitability of our domestic grooming, skin care and hair care solutions products business.

 

The Housewares segment’s operating income before impairment charges decreased $0.55 million, or 4.1 percent, for the fiscal quarter ended November 30, 2010, when compared to the same period last year. The quarter-over-quarter decrease in operating income was principally due to a lower overall gross profit margin due to higher than usual close-out sales, increased inbound freight and commodity costs, and product mix changes.  The segment’s operating income before impairment charges increased $2.09 million, or 6.3 percent, for the nine months ended November 30, 2010, when compared to the same period last year.

 

Operating income before impairment charges for each operating segment is computed based on net sales revenue, less cost of goods sold and any SG&A associated with the segment, not including impairment charges. The SG&A used to compute each segment’s operating income includes SG&A directly associated with the segment, plus overhead expenses that are allocable to the segment.

 

Impairment Charges:

 

The Company conducts its annual test of impairment of goodwill and indefinite-lived intangible assets in the first quarter of each fiscal year. The Company also tests for impairment if events or circumstances indicate that it is more likely than not that the fair value of a reporting unit or an indefinite-lived intangible asset is below its carrying amount.

 

As a result of its testing during the fiscal quarter ended May 31, 2010, the Company recorded a non-cash impairment charge of $0.50 million ($0.49 million after tax).  The charge was related to an indefinite-lived trademark in our Personal Care segment which was written down to its fair value, determined on the basis of future discounted cash flows using the relief from royalty method.

 

34



 

During the fiscal quarter ended August 31, 2009, a significant customer decided to discontinue carrying our Skin Milk® brand of skin care products.   Sales to this customer accounted for a substantial portion of the total sales of this brand and, accordingly, non-cash impairment charges were recorded to write off the remaining $0.90 million ($0.89 million after tax) in carrying value of the associated trademark.

 

Interest expense and nonoperating income (expense), net:

 

Interest expense for the three- and nine-month periods ended November 30, 2010 was $2.08 and $6.38 million, respectively, compared to $2.15 and $8.19 million, respectively, for the same periods last year.  Interest expense was lower when compared to the previous period primarily due to lower outstanding debt.

 

Nonoperating income (expense), net, for the three- and nine-month periods ended November 30, 2010 was $0.16 and $0.49 million, respectively, compared to $0.13 and $0.93 million, respectively, for the same periods last year. The following table sets forth, for the periods indicated, the key components of nonoperating income (expense), net as a year-over-year percentage change and as a percentage of net sales revenue:

 

NONOPERATING INCOME (EXPENSE), NET

(dollars in thousands)

 

 

Quarter Ended November 30,

 

 

 

 

 

% of Sales Revenue, net

 

 

2010

 

2009

 

 

$ Change

 

% Change

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

$

152

 

$

105

 

 

$

47

 

44.8%

 

0.1%

 

0.1%

Miscellaneous other income (expense), net

 

4

 

20

 

 

(16

)

-80.0%

 

0.0%

 

0.0%

Total nonoperating income (expense), net

 

$

156

 

$

125

 

 

$

31

 

24.8%

 

0.1%

 

0.1%

 

 

 

Nine Months Ended November 30,

 

 

 

 

 

% of Sales Revenue, net

 

 

2010

 

2009

 

 

$ Change

 

% Change

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

$

402

 

$

426

 

 

$

(24

)

-5.6%

 

0.1%

 

0.1%

Unrealized gains on securities

 

-    

 

420

 

 

(420

)

-100.0%

 

0.0%

 

0.1%

Miscellaneous other income (expense), net

 

88

 

81

 

 

7

 

8.6%

 

0.0%

 

0.0%

Total nonoperating income (expense), net

 

$

490

 

$

927

 

 

$

(437

)

-47.1%

 

0.1%

 

0.2%

 

Income tax expense:

 

Income tax expense for the three- and nine-month periods ended November 30, 2010 was 8.6 and 9.4 percent, respectively, of income before income taxes compared to 11.2 and 10.4 percent, respectively, for the same periods last year. The decrease in effective tax rates year-over-year is partially due to the reversal of certain reserves for uncertain tax positions during the three- and nine-month periods ended November 30, 2010.  The remaining fluctuations in our effective tax rates for the periods presented are generally attributable to shifts in the mix of taxable income earned between the various high and low tax rate jurisdictions in which we conduct our business.

 

Net income:

 

Our net income was $27.06 and $68.92 million, respectively, for the three- and nine-month periods ended November 30, 2010 compared to $24.73 and $55.15 million for the same periods last year, representing period-over-period net income increases of 9.4 and 25.0 percent, respectively.   Our diluted earnings per share was $0.86 and $2.20 respectively, for the three- and nine-month periods ended November 30, 2010 compared to $0.80 and $1.79, respectively, for the same periods last year, representing period-over-period diluted earnings per share increases of 7.5 and 22.9 percent, respectively.

 

35


 


 

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

 

Selected measures of our liquidity and capital resources for the nine-month periods ended November 30, 2010 and 2009 are shown below:

 

SELECTED MEASURES OF OUR LIQUIDITY AND CAPITAL RESOURCES

 

 

Nine Months Ended November 30,

 

 

2010

 

2009

 

 

 

 

 

 

 

Accounts Receivable Turnover (Days) (1)

 

68.0

 

70.6

 

Inventory Turnover (Times) (1)

 

2.7

 

2.3

 

Working Capital (in thousands)

 

$219,518

 

$234,599

 

Current Ratio

 

2.3 : 1

 

3.0 : 1

 

Debt to Equity Ratio (2)

 

20.0%

 

23.8%

 

Return on Average Equity (1) (3)

 

14.1%

 

-6.0%

 

 

(1) Accounts receivable turnover, inventory turnover and return on average equity computations use 12-month trailing sales, cost of sales, or net income components as required by the particular measure.   The current and four prior quarters’ ending balances of accounts receivable, inventory and equity are used for the purposes of computing the average balance component as required by the particular measure.

 

(2)  Debt is defined as all debt outstanding at the balance sheet date.  This includes the sum of the following lines on our consolidated balance sheets: “Long-term debt, current maturities” and “Long-term debt, excluding current maturities.”

 

(3)  Return on average equity for the nine months ended November 30, 2009 reflects the impact of non-cash impairment charges of $99.51 million ($99.06 million after tax) recorded in the fourth quarter of fiscal 2009.

 

Operating activities:

 

Operating activities provided $33.60 million of cash during the first nine months of fiscal 2011, compared to $97.93 million of cash provided during the same period in fiscal 2010.  The decrease in operating cash flow was primarily due to the timing of fluctuations in working capital components, particularly an increase in inventory when compared year-over-year.

 

Accounts receivable increased $42.69 million to $152.41 million as of November 30, 2010, compared to $109.72 million at the end of fiscal 2010.  The increase was due to trade receivables acquired with the Pert Plus and Sure business and overall net sales revenue growth.  Accounts receivable turnover improved to 68.0 days at November 30, 2010 from 70.6 days at November 30, 2009.  This calculation is based on a rolling five quarter accounts receivable balance.

 

Inventories increased $28.29 million to $152.31 million as of November 30, 2010, compared to $124.02 million at the end of fiscal 2010.  Inventory turnover improved to 2.7 times at November 30, 2010 compared to 2.3 times at November 30, 2009.

 

Working capital decreased to $219.52 million at November 30, 2010, compared to $234.60 million at November 30, 2009.  Our current ratio decreased to 2.3:1 at November 30, 2010, compared to 3.0:1 at November 30, 2009. The decrease in our working capital and current ratio was primarily caused by $50 million of long-term debt scheduled to mature in June 2011, which became classified as a current liability during the quarter ended August 31, 2010.

 

36



 

Investing activities:

 

Investing activities used $71.67 million of cash during the nine months ended November 30, 2010. Highlights of those activities follow:

 

·    In addition to certain capital assets acquired in connection with the Pert Plus hair care and Sure antiperspirant and deodorant acquisition discussed immediately below, we spent $1.19 million on molds and tooling, $0.87 million on information technology infrastructure, $0.52 million on various other fixed asset additions, and $0.45 million on the development of new patents.

 

·    We used $69.00 million of cash to acquire accounts receivable, finished goods inventories, prepaid expenses, goodwill, patents, trademarks, tradenames, product design specifications, production know-how, certain fixed assets, distribution rights and customer lists, less certain product related operating accruals and other current liabilities of the Pert Plus hair care and Sure antiperspirant and deodorant businesses from Innovative Brands, LLC.

 

·     We liquidated $0.30 million of auction rate securities (“ARS”) at par.

 

Financing activities:

 

Financing activities used $1.52 million of cash during the nine months ended November 30, 2010.  Highlights of those activities follow:

 

·                  We paid a $3 million installment on long-term debt.

 

·                  We repurchased and retired 80,000 shares of common stock at a total purchase price of $1.80 million, for a $22.49 per share average price.

 

·                  Employees and directors exercised options to purchase 141,325 shares of common stock, providing $3.06 million of cash, including related tax benefits.

 

·                  Purchases of common stock through our employee stock purchase plan provided $0.22 million of cash.

 

Termination of 2004 Revolving Line of Credit Agreement and Other Debt Agreements:

 

In June 2004, we entered into a Revolving Line of Credit Agreement (the “2004 RCA”) with Bank of America, N.A. that provided for a total revolving commitment of up to $50 million. On December 31, 2010, we terminated the 2004 RCA and, in connection with our acquisition of Kaz, after having entered into a new Revolving Line of Credit Agreement (the “2010 RCA”) with Bank of America, N.A. on December 30, 2010. For additional information regarding the terms and conditions of the 2004 RCA, see Note 10 to the accompanying consolidated condensed financial statements.   For additional information regarding our acquisition of Kaz, see Note 18 to the accompanying consolidated condensed financial statements.

 

2010 Revolving Line of Credit Agreement and Other Debt Agreements:

 

The 2010 RCA provides for an unsecured revolving commitment of up to $150 million, subject to the terms and limitations described below.  The commitment under the 2010 RCA terminates on December 30, 2015.  We also simultaneously entered into a $100 million unsecured Term Loan Credit Agreement (the “TLCA”) with Bank of America, N.A., which matures on March 30, 2011. We intend to repay in full and terminate the TLCA, replacing it with permanent long-term financing prior to the maturity date of the TLCA.  The following table

 

37



 

summarizes the sources and consideration paid for Kaz, subject to certain future adjustments, including an adjustment for estimated closing date working capital.

 

KAZ, INC - SOURCES OF CONSIDERATION PAID AT DECEMBER 31, 2010

(in thousands)

 

 

 

Cash

 

$

72,037

 

Advances under the 2010 RCA

 

94,000

 

Loans under the TLCA

 

100,000

 

Total consideration paid

 

$

266,037

 

 

Borrowings under the 2010 RCA accrue interest at a “Base Rate” plus a margin of 0.25 to 1.375 percent per annum based on the Leverage Ratio (as defined in the 2010 RCA) at the time of borrowing.  The base rate is equal to the highest of the Federal Funds Rate (as defined in the 2010 RCA) plus 0.50 percent, Bank of America’s prime rate or the one month LIBOR rate plus 1 percent.  Alternatively, if we elect, borrowings accrue interest based on the respective 1, 2, 3, or 6-month LIBOR rate plus a margin of 1.25 to 2.375 percent per annum based upon the Leverage Ratio at the time of the borrowing. We incur loan commitment fees at a rate ranging from 0.30 to 0.50 percent per annum on the unused balance of the 2010 RCA.  We incur letter of credit fees under the 2010 RCA at a rate ranging from 1.25 to 2.375 percent per annum on the face value of any letter of credit. The TLCA accrues interest at the “Base Rate” plus a margin of 2.00 percent per annum, or alternatively, if we elect, at the one month LIBOR rate plus a margin of 3.00 percent per annum. Outstanding letters of credit reduce the borrowing availability under the 2010 RCA on a dollar for dollar basis. The 2010 RCA, the TLCA and our other debt are unconditionally guaranteed, on a joint and several basis, by the parent company, Helen of Troy Limited and/or certain subsidiaries.

 

The 2010 RCA, the TLCA and our other debt agreements require the maintenance of certain maximum debt leverage, interest coverage ratios, specify minimum consolidated net worth levels and contain other customary covenants, which, among other things, restrict us from incurring liens on any of our properties, except under certain conditions set forth therein, and limit our ability to pay dividends and repurchase shares of our common stock. As of December 31, 2010, our debt agreements effectively limited our ability to incur more than an estimated $147.44 million of additional debt from all sources, including draws on the 2010 RCA.  All of our long-term debt, including our Senior Notes, is unconditionally guaranteed by the parent company, Helen of Troy Limited and/or certain subsidiaries on a joint and several basis.  We are currently in compliance with the terms of the 2010 RCA, the TLCA and our other debt agreements.

 

In connection with the 2010 RCA and TLCA, the Company has incurred $2.05 million in new debt acquisition costs through December 31, 2010 that will be amortized over the terms of the associated agreements.

 

As of November 30, 2010, we had an aggregate principal balance of $131.00 million of Senior Notes with varying maturities due through June 2014. All of our Senior Notes are unconditionally guaranteed by the parent company, Helen of Troy Limited and/or certain subsidiaries on a joint and several basis.

 

38



 

Contractual obligations and commercial commitments:

 

Our contractual obligations and commercial commitments, at November 30, 2010, were:

 

PAYMENTS DUE BY PERIOD - TWELVE MONTHS ENDED NOVEMBER 30:

(in thousands)

 

 

 

 

2011

 

2012

 

2013

 

2014

 

2015

 

After

 

 

 

Total

 

1 year

 

2 years

 

3 years

 

4 years

 

5 years

 

5 years

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Term debt - fixed rate

 

$

6,000

 

$

3,000

 

$

3,000

 

$

-

 

$

-

 

$

-

 

$

-

 

Term debt - floating rate (1)

 

125,000

 

50,000

 

-

 

-

 

75,000

 

-

 

-

 

Long-term incentive plan payouts

 

4,968

 

2,108

 

1,955

 

905

 

-

 

-

 

-

 

Interest on fixed rate debt

 

489

 

353

 

136

 

-

 

-

 

-

 

-

 

Interest on floating rate debt (1)

 

17,870

 

6,225

 

4,508

 

4,508

 

2,629

 

-

 

-

 

Open purchase orders

 

94,289

 

94,289

 

-

 

-

 

-

 

-

 

-

 

Minimum royalty payments

 

69,877

 

6,534

 

6,821

 

6,075

 

4,938

 

4,969

 

40,540

 

Advertising and promotional

 

79,665

 

12,332

 

6,271

 

5,671

 

5,324

 

5,467

 

44,600

 

Operating leases

 

10,558

 

1,987

 

1,587

 

1,358

 

1,298

 

1,063

 

3,265

 

Capital spending commitments - Software Upgrade

 

6,573

 

6,573

 

-

 

-

 

-

 

-

 

-

 

Total contractual obligations (2)

 

$

415,289

 

$

183,401

 

$

24,278

 

$

18,517

 

$

89,189

 

$

11,499

 

$

88,405

 

 

(1) The Company uses interest rate hedge agreements (the “swaps”)  in conjunction with its unsecured floating interest rate $50 million, 7 year and $75 million, 10 year Senior Notes.  The swaps are a hedge of the variable LIBOR rates used to reset the floating rates on these Senior Notes.  The swaps effectively fix the interest rates on the 7- and 10-year Senior Notes at 5.89 and 6.01 percent, respectively.   Accordingly, the future interest obligations related to this debt have been estimated using these rates.

 

(2)  In addition to the contractual obligations and commercial commitments in the table above, as of November 30, 2010, we have recorded a provision for our uncertain tax positions of $1.33 million. We are unable to reliably estimate the timing of future payments, if any, related to uncertain tax positions; therefore, we have excluded these tax liabilities from the table above.

 

As previously discussed, in connection with our acquisition of Kaz, the Company terminated the 2004 RCA and entered into the 2010 RCA, which provides for an unsecured revolving credit commitment of up to $150 million.  The commitment under the 2010 RCA terminates on December 30, 2015.  In addition, the Company entered into the TLCA, which provides for $100 million of unsecured term loans.  In total, on December 31, 2010, these new borrowings funded $194 million of Kaz’s acquisition price, with the remaining purchase price funded with cash on hand.  These transactions are not reflected in the above table because they were not contractual obligations at November 30, 2010.  The TLCA matures on March 30, 2010.  We intend to repay in full and terminate the TLCA with permanent long-term financing prior to the maturity date of the TLCA.

 

Off-balance sheet arrangements:

 

We have no existing activities involving special purpose entities or off-balance sheet financing.

 

39



 

Current and future capital needs:

 

As of November 30, 2010, we have no outstanding borrowings and $0.20 million of open letters of credit under the 2004 RCA.   As of December 31, 2010, after giving effect to the cash on hand used to acquire Kaz and the borrowings under the 2010 RCA and TLCA, we have approximately $20 million of cash on hand and approximately $55 million of revolving loan availability.  Based on our current financial condition and current operations, we believe that cash flows from operations, cash on hand and available financing sources (including our availability under the 2010 RCA) will continue to provide sufficient capital resources to fund our foreseeable short- and long-term liquidity requirements.  We expect our continuing capital needs to stem primarily from the need to purchase sufficient levels of inventory and to carry normal levels of accounts receivable on our balance sheet. In addition, we continue to evaluate new acquisition opportunities on a regular basis and may augment our internal growth with acquisitions of complementary businesses or product lines. We may finance new acquisition activity with available cash, the issuance of common stock, additional debt or other sources of financing, depending upon the size and nature of any such transaction and the status of the capital markets at the time of such acquisition.

 

The Company may elect to repurchase additional common stock from time to time based upon its assessment of its liquidity position and market conditions at the time, and subject to limitations contained in its debt agreements.  For additional information, see Part II, Item 2. “Unregistered Sales of Equity Securities and Use of Proceeds” in this Form 10-Q.

 

CRITICAL ACCOUNTING POLICIES

 

The SEC defines critical accounting policies as those that are both most important to the portrayal of a company’s financial condition and results, and require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. For a discussion of our critical accounting policies, see Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, under the heading “Critical Accounting Policies” in our annual report on Form 10-K for the year ended February 28, 2010. There have been no material changes to the Company’s critical accounting policies from the information provided in our Form 10-K.

 

NEW ACCOUNTING PRONOUNCEMENTS

 

See Note 2 – “New Accounting Pronouncements,” to the accompanying consolidated condensed financial statements of this report, for a discussion of the status and potential impact of new accounting pronouncements.

 

40


 


 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Changes in currency exchange rates, interest rates and the liquidity of our investments are our primary financial market risks.

 

Foreign currency risk:

 

Our functional currency is the U.S. Dollar. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. During the three- and nine-month periods ended November 30, 2010, approximately 16 and 13 percent, respectively, of our net sales revenue were in foreign currencies. During the three- and nine-month periods ended November 30, 2009, approximately 16 and 15 percent, respectively, of our net sales revenue were in foreign currencies. These sales were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars, Chilean Pesos, Peruvian Soles and Venezuelan Bolivares Fuertes. We make most of our inventory purchases from the Far East and use the U.S. Dollar for such purchases. In our consolidated condensed statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets and deferred tax liabilities, are recognized in their respective income tax lines, and all other foreign exchange gains and losses are recognized in SG&A.

 

We identify foreign currency risk by regularly monitoring our foreign currency-denominated transactions and balances.  Where operating conditions permit, we reduce foreign currency risk by purchasing most of our inventory with U.S. Dollars and by converting cash balances denominated in foreign currencies to U.S. Dollars.

 

We have historically hedged against certain foreign currency exchange rate-risk by using a series of forward contracts designated as cash flow hedges to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar.  In these transactions, we execute a forward currency contract that will settle at the end of a forecasted period.  Because the size and terms of the forward contract are designed so that it’s fair market value will move in the opposite direction and approximate magnitude of the underlying foreign currency’s forecasted exchange gain or loss during the forecasted period, a hedging relationship is created.  To the extent that we forecast the expected foreign currency cash flows from the period we enter into the forward contract until the date it will settle with reasonable accuracy, we significantly lower or materially eliminate a particular currency’s exchange risk exposure over the life of the related forward contract.  We enter into these types of agreements where we believe we have meaningful exposure to foreign currency exchange risk and the hedge pricing appears reasonable.  It is not practical for us to hedge all our exposures, nor are we able to project in any meaningful way the possible effect and interplay of all foreign currency fluctuations on translated amounts or future earnings.  This is due to our constantly changing exposure to various currencies, the fact that each foreign currency reacts differently to the U.S. Dollar, and the significant number of currencies involved. Accordingly, we will always be subject to foreign exchange rate-risk on exposures we have not hedged, and these risks may be material.  We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes.

 

Interest rate risk:

 

Interest on our long-term debt outstanding as of November 30, 2010 is both floating and fixed. Fixed rates are in place on $6 million of Senior Notes at 7.24 percent and floating rates are in place on $125 million of Senior Notes, which reset as described in Note 13 to the accompanying consolidated condensed financial statements, and have been effectively converted to fixed rate debt using interest rate swaps, as described below.

 

Our levels of debt, certain additional draws against the 2004 RCA (whose interest rates can vary with the term of each draw) and the uncertainty regarding the level of future interest rates, increase our risk profile. We manage our floating rate debt using interest rate swaps (the “swaps”). As of November 30, 2010, we had two

 

41



 

swaps that converted an aggregate notional principal of $125 million from floating interest rate payments under our 7- and 10-year Senior Notes to fixed interest rate payments at 5.89 and 6.01 percent, respectively. In the swap transactions, we maintain two contracts to pay fixed rates of interest on an aggregate notional principal amount of $125 million at rates of 5.04 and 5.11 percent on our 7- and 10-year Senior Notes, respectively, while simultaneously receiving floating rate interest payments set at 0.29 percent as of November 30, 2010 on the same notional amounts. The fixed rate side of the swap will not change over the life of the swap. The floating rate payments are reset quarterly based on three month LIBOR. The resets are concurrent with the interest payments made on the underlying debt. Changes in the spread between the fixed rate payment side of the swap and the floating rate receipt side of the swap fully offset the change in any period of the underlying debt’s floating rate payments. These swaps are used to reduce the Company’s risk of increased interest costs; however, when interest rates drop significantly below the swap rates, we lose the benefit that our floating rate debt would provide, if not managed with swaps. The swaps are considered highly effective.

 

The following tables summarize the fair values of our various derivative instruments at November 30, 2010 and February 28, 2010:

 

FAIR VALUES OF DERIVATIVE INSTRUMENTS IN THE CONSOLIDATED BALANCE SHEETS

(in thousands)

November 30, 2010

 

 

 

 

 

 

 

 

 

 

 

 

Accrued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

Final

 

 

 

Derivative

 

Derivative

 

and Other

 

Derivative

 

 

 

 

 

Settlement

 

Notional

 

Assets,

 

Assets,

 

Current

 

Liabilities,

 

Designated as hedging instruments

 

Hedge Type

 

Date

 

Amount

 

Current

 

Noncurrent

 

Liabilities

 

Noncurrent

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency contracts - sell Pounds

 

Cash flow

 

2/2012

 

£

10,700

 

$

355

 

$

156

 

$

-

 

$

-

 

Currency contracts - sell Canadian

 

Cash flow

 

12/2011

 

$

8,000

 

80

 

43

 

-

 

-

 

Currency contracts - sell Euros

 

Cash flow

 

2/2012

 

7,000

 

121

 

-

 

-

 

-

 

Subtotal

 

 

 

 

 

 

 

556

 

199

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

Cash flow

 

6/2014

 

$

125,000

 

-

 

-

 

4,222

 

7,621

 

Total fair value

 

 

 

 

 

 

 

$

556

 

$

199

 

$

4,222

 

$

7,621

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

February 28, 2010

 

 

 

 

 

 

 

 

 

 

 

 

Accrued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

Final

 

 

 

Derivative

 

Derivative

 

and Other

 

Derivative

 

 

 

 

 

Settlement

 

Notional

 

Assets,

 

Assets,

 

Current

 

Liabilities,

 

Designated as hedging instruments

 

Hedge Type

 

Date

 

Amount

 

Current

 

Noncurrent

 

Liabilities

 

Noncurrent

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency contracts - sell Pounds

 

Cash flow

 

2/2011

 

£

5,000

 

$

651

 

$

-

 

$

-

 

$

-

 

Currency contracts - sell Canadian

 

Cash flow

 

12/2010

 

$

6,000

 

144

 

-

 

-

 

-

 

Subtotal

 

 

 

 

 

 

 

795

 

-

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

Cash flow

 

6/2014

 

$

125,000

 

-

 

-

 

4,951

 

7,070

 

Total fair value

 

 

 

 

 

 

 

$

795

 

$

-      

 

$

4,951

 

$

7,070

 

 

We expect that as currency market conditions warrant, and our foreign denominated transaction exposure grows, we will continue to execute additional contracts in order to hedge against certain potential foreign exchange losses.

 

Counterparty credit risk:

 

Financial instruments, including foreign currency contracts and interest rate swaps, expose us to counterparty credit risk for nonperformance.  We manage our exposure to counterparty credit risk through only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.  Although our theoretical credit risk is the replacement cost at the then estimated fair value of these instruments, we believe that the risk of incurring credit risk losses is remote.

 

42



 

Risks inherent in cash, cash equivalents and investment holdings:

 

Our cash, cash equivalents and investments are subject to interest rate risk, credit risk and liquidity risk.  Cash consists of both interest bearing and non-interest bearing disbursement or short-term investment accounts.  Cash equivalents consist of commercial paper and money market investment accounts.  Long-term investments consist of AAA rated ARS.  The following table summarizes cash, cash equivalents and long-term investments we held at November 30, 2010 and February 28, 2010:

 

CASH, CASH EQUIVALENTS AND LONG-TERM INVESTMENTS

(in thousands)

 

 

November 30, 2010

 

February 28, 2010

 

 

 

Carrying

 

Range of

 

Carrying

 

Range of

 

 

 

Amount

 

Interest Rates

 

Amount

 

Interest Rates

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

Cash, interest and non-interest-bearing accounts - unrestricted

 

$

44,754

 

0.00 to 1.65%

 

$

6,234

 

0.00 to 2.00%

 

Cash, interest and non-interest-bearing accounts - restricted

 

1,377

 

0.00 to 1.25%

 

1,053

 

0.00 to 2.50%

 

Commercial paper

 

8,640

 

0.13 to 0.16%

 

88,822

 

0.03 to 0.18%

 

Money market accounts

 

15,852

 

0.07 to 3.66%

 

14,099

 

0.01 to 3.98%

 

Total cash and cash equivalents

 

$

70,623

 

 

 

$

110,208

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term investments - auction rate securities

 

$

20,223

 

1.61 to 2.75%

 

$

20,534

 

1.73 to 8.44%

 

 

Our cash balances at November 30, 2010 and February 28, 2010 include restricted cash of $1.38 and $1.05 million, respectively, denominated in Venezuelan Bolivares Fuertes, shown above under the heading “Cash, interest and non-interest-bearing accounts – restricted.” The balances arise from our operations within the Venezuelan market.  The Venezuelan government enforces restrictions on transfers of cash out of the country and controls exchange rates.  We have made formal applications to repatriate this cash at an official exchange rate currently pertinent to us, which is 4.30 Bolivares Fuertes to $1.00; however, the Company has not yet received approval of these applications.  Until we are able to officially repatriate cash from Venezuela, we intend to use these cash balances in-country to continue to fund operations.  We do not otherwise rely on these restricted funds as a source of liquidity.

 

Most of our cash equivalents and investments are in commercial paper, money market accounts and ARS with frequent rate resets; therefore, we believe there is no material interest rate risk.  In addition, our commercial paper and ARS are from issuers with high credit ratings; therefore, we believe the commercial paper and ARS do not present a significant credit risk.

 

We hold investments in ARS collateralized by student loans (with underlying maturities from 18 to 35 years).  Substantially all of the collateral is guaranteed by the U.S. government under the Federal Family Education Loan Program.  Liquidity for these securities was normally dependent on an auction process that reset the applicable interest rate at predetermined intervals, ranging from 7 to 35 days.  Beginning in February 2008, the auctions for the ARS held by us and others were unsuccessful, requiring us to hold them beyond their typical auction reset dates. Auctions fail when there is insufficient demand.  However, this does not represent a default by the issuer of the security. Upon an auction’s failure, the interest rates reset based on a formula contained in the security.  The securities will continue to accrue interest and be auctioned until one of the following occurs: the auction succeeds; the issuer calls the securities; or the securities mature.  ARS are currently classified as non-current assets held for sale under the heading “Other assets” in our accompanying consolidated condensed balance sheets.

 

43



 

INFORMATION REGARDING FORWARD-LOOKING STATEMENTS

 

Certain written and oral statements made by our Company and subsidiaries of our Company may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made in this report, in other filings with the SEC, in press releases, and in certain other oral and written presentations. Generally, the words “anticipates”, “believes”, “expects”, “plans”, “may”, “will”, “should”, “seeks”, “estimates”, “project”, “predict”, “potential”, “continue”, “intends”, and other similar words identify forward-looking statements. All statements that address operating results, events or developments that we expect or anticipate will occur in the future, including statements related to sales, earnings per share results and statements expressing general expectations about future operating results, are forward-looking statements and are based upon the Company’s current expectations and various assumptions. The Company believes there is a reasonable basis for its expectations and assumptions, but there can be no assurance that the Company will realize its expectations or that the Company’s assumptions will prove correct.  Forward-looking statements are subject to risks that could cause them to differ materially from actual results.  Accordingly, the Company cautions readers not to place undue reliance on forward-looking statements. We believe that these risks include, but are not limited to, the risks described in Part 1, “Item 1A. Risk Factors” of our annual report on Form 10-K for the year ended February 28, 2010 and risks otherwise described from time to time in our SEC reports as filed.  Such risks, uncertainties and other important factors include, among others:

 

·                  the departure and recruitment of key personnel;

 

·                  our ability to deliver products to our customers in a timely manner and according to their fulfillment standards;

 

·                  our projections of product demand, sales and net income (including the Company’s guidance for Kaz’s net sales revenues and the expectation that the acquisition will be accretive) are highly subjective in nature and future net sales revenues and net income could vary in a material amount from such projections;

 

·                  expectations regarding the acquisition of Kaz and any other future acquisitions, including our ability to realize anticipated cost savings, synergies and other benefits along with our ability to effectively integrate Kaz and other acquired businesses;

 

·                  our relationship with key customers and licensors;

 

·                  the costs of complying with the business demands and requirements of large sophisticated customers;

 

·                  our dependence on foreign sources of supply and foreign manufacturing, and associated operational risks including but not limited to long lead times, consistent local labor availability and capacity, and timely availability of sufficient shipping carrier capacity;

 

·                  the impact of changing costs of raw materials and energy on cost of goods sold and certain operating expenses;

 

·                  the inability to liquidate auction rate securities;

 

·                  circumstances which may contribute to future impairment of goodwill, intangible or other long-lived assets;

 

·                  the risks associated with the use of trademarks licensed from third parties;

 

44



 

·                  our dependence on the strength of retail economies and vulnerabilities to a prolonged economic downturn;

 

·                  our ability to develop and introduce a continuing stream of innovative new products to meet changing consumer preferences;

 

·                  the potential impact of disruptions in U.S. and international credit markets;

 

·                  currency exchange rate fluctuations, trade barriers, exchange controls, expropriation and other risks associated with foreign operations;

 

·                  our leverage and the constraints it may impose on our ability to manage our cash resources and operate our business;

 

·                  the risks associated with tax audits and related disputes with taxing authorities;

 

·                  the risks of potential changes in laws, including tax laws and the complexities of compliance with such laws; and

 

·                  our ability to continue to avoid classification as a controlled foreign corporation.

 

We undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise.

 

45



 

ITEM 4. CONTROLS AND PROCEDURES

 

DISCLOSURE CONTROLS AND PROCEDURES

 

Our management, under the supervision and with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), maintains disclosure controls and procedures as defined in Rules 13a-15(e) under the Exchange Act that are designed to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosures. Because of inherent limitations, disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of disclosure controls and procedures are met.

 

Our management, including our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended November 30, 2010. Based upon that evaluation, the CEO and CFO concluded that our disclosure controls and procedures were effective at a reasonable level of assurance as of November 30, 2010, the end of the period covered by this report.

 

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

 

In connection with the evaluation described above, we identified no change in our internal control over financial reporting as defined in Rule 13a-15(f) that occurred during our fiscal quarter ended November 30, 2010, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

46



 

PART II.   OTHER INFORMATION

 

ITEM 1.   LEGAL PROCEEDINGS

 

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations, or liquidity.

 

ITEM 1A.   RISK FACTORS

 

The ownership of our common stock involves a number of risks and uncertainties.  When evaluating the Company and our business before making an investment decision regarding our securities, potential investors should carefully consider the risk factors and uncertainties described in Part 1, “Item 1A. Risk Factors” of our annual report on Form 10-K for the fiscal year ended February 28, 2010.  Since the filing of our annual report on Form 10-K, there have been no material changes in our risk factors from those disclosed therein.

 

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Under the latest program approved by our Board of Directors, as of November 30, 2010, we are authorized to purchase up to 1,200,650 shares of common stock in the open market or through private transactions. During the fiscal quarter ended November 30, 2010 we did not repurchase any common stock.

 

ITEM 6.    EXHIBITS

 

(a)          Exhibits

 

31.1

 

Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

31.2

 

Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

32

 

Joint certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

47



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

HELEN OF TROY LIMITED

 

(Registrant)

 

 

 

 

Date:    January 10, 2011

/s/ Gerald J. Rubin

 

Gerald J. Rubin

 

Chairman of the Board, Chief
Executive Officer, President, Director

 

and Principal Executive Officer

 

 

 

 

Date:    January 10, 2011

/s/ Thomas J. Benson

 

Thomas J. Benson

 

Senior Vice-President

 

and Chief Financial Officer

 

 

 

 

Date:    January 10, 2011

/s/ Richard J. Oppenheim

 

Richard J. Oppenheim

 

Financial Controller

 

and Principal Accounting Officer

 

48



 

Index to Exhibits

 

31.1*

 

Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

31.2*

 

Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

32**

 

Joint Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

*   Filed herewith.

 

** Furnished herewith.

 

49